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ABSTRACT 
Systemic lupus erythematosus (SLE) is a chronic inflammatory 
disease of unknown etiology. Its affects multiple organ systems and 
is characterised by periods of disease activity and remission. The 
unpredictable course, treatment and symptomatology of SLE can 
impact upon the social and personal resources of sufferers. Social 
resources are those variables influenced by external events, they 
include stress, uplifts, social support and social networks. Personal 
resources are mediated more by individuals' perceptions and 
include self—efficacy and coping (problem— and emotion—focused). 
Deteriorations in social and personal resources accompanying 
chronic illness suggest a Disease Exacerbation Model. This model 
proposes that the course of chronic illness is mediated by 
decrements in social and personal resources which, in turn, 
influence disease outcomes such as physical disability, psychosocial 
disruption and psychological distress. 
The present investigation used a comparative design to test the 
Disease Exacerbation Model. The participants in the study were 34 
individuals with a diagnosis of SLE, 37 multiple sclerosis (MS) 
sufferers and 38 people without a history of chronic illness. The 
control group was matched to the chronic illness groups for age, 
marital status, gender and socioeconomic status. Data were 
collected by using standardised psychological questionnaires. These 
included measures of stress, hassles, social network, social support, 
self-efficacy, coping, psychological distress, physical disability and 
psychosocial disruption. 
Individuals with SLE and a chronic illness comparison group (MS) 
reported significantly fewer uplifts, less social support, more 
emotion—focused coping, as well as greater disability, distress and 
psychological disruption when compared with healthy people. 
There were, however, no significant decrements in network size or 
problem—focused coping and no significant increases in hassles. 
Except for the MS group reporting significantly more disability than 
SLE sufferers, no other differences were evident between the 
chronic illness groups. The correlations between social, personal 
and disease outcome measures suggest that group differences may 
involve somewhat different underlying processes. For example, 
social support mediated psychological distress for SLE sufferers, but 
not for the MS group. 
To determine which social and personal resource variables are most 
salient to disease outcome, stepwise multiple regression analyses 
were performed. For SLE sufferers, increasing hassles and fewer 
uplifts were associated with elevated psychological distress. 
Although higher hassle levels and decreasing social support were 
both correlated with more psychosocial disruption, in the stepwise 
regression only hassles significantly predicted this disease outcome. 
Physical disability levels were not significantly related to any social 
or personal resource measures. 
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Chapter One 
Systemic Lupus Erythematosus: An Overview 
2 
1.1.0 INTRODUCTION • 
This section reviews the medical aspects of systemic lupus 
erythematosus (SLE or lupus). It is included to familiarise the reader 
with the symptomatology, treatment and etiology of lupus. The 
chapter also provides the foundations for understanding research 
reviewed in later sections and discusses how the physical 
characteristics of SLE may precipitate psychological dysfunction. 
DESCRIPTION 
A concise and informative description of SLE is provided by Wallace 
and Dubois (1987); 
"Systemic lupus erythematosus is a clinical syndrome 
of unknown cause or causes characterised by 
inflammation and multisystem involvement. It 
displays a widely variable presentation and course 
and is subject to multiple remissions and 
exacerbations in one or more systems. In 
approximately 30% of cases, the disease is induced by 
known drugs." 
(p.15) 
PATHOGENESIS 
To understand the pathogenesis of SLE it is necessary to briefly explain 
how the immune system functions. Whenever foreign organisms 
[antigens] such as viruses or bacteria invade, the immune system is 
mobilised. The first line of defence involves phagocytes engulfing 
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and digesting antigens (O'Donnnell, Silove & Wakefield, 1988; Table 
1). When the antigen is digested, phagocytes bind with antigen 
presenting cells. These latter cells then incorporate the nuclear 
material of the antigen into their membrane so it may be recognised 
by other immune defences. 
Table 1: Cellular components of the immune system. 
(after O'Donnnell et al., 1988) 
1. Phagocytes 
monocytes 
macrophages 
polymorphonucle neutrophils 
2. Antigen Presenting cells 
monocytes 
macrophages 
accessory cells 
3. T—lymphocytes 
regulatory cells 
helper cells 
suppressor cells 
effector cells 
delayed hypersensitivity 
cytotoxic T—lymphocytes 
4. Natural Killer cells 
5. B—lymphocytes 
plasma cells 
memory cells 
When antigen presenting cells bind with T—lymphocyte helper cells 
interleukin-1 is secreted (Hardy, 1985). Interleukin-1 causes the 
proliferation of helper cells and these secrete interleukin-2 which has 
several functions. It stimulates T—suppressor cells that switch off the 
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immune response when the time is appropriate. Interleukin-2 also 
stimulates the reproduction of T-killer cells that will either bind with 
the antigen presenting cell or engulf the antigen directly. Finally, 
interleukin-2 stimulates B-lymphocytes to produce antibodies 
(immunoglobulins) that bind with the invading antigen so it is easily 
recognised by T-cells. B-lymphocytes are antigen specific and if the 
antigen invades again, they are mobilised immediately (Blau & 
Schultz, 1984). 
Autoimmune diseases are characterised by immune attacks toward 
native body proteins. In lupus the immune attacks are directed 
toward deoxyribonucleic acid (DNA or the genetic material of cells). 
Since all cells contain DNA, every organ is a potential target for 
immune attacks. Although the etiology of immune attacks is not 
known, immune irregularities associated with SLE are well 
documented. Individuals with SLE have lower interleukin-2 levels, 
suppressor cells fail to switch-off the immune system and 
B-lymphocytes are constantly active whether or not there is infection 
(Blau & Schultz, 1984). 
SYMPTOMATOLOGY 
Since all organs are at risk in SLE, there is no typical presentation of 
patients. Signs and symptoms of SLE are, however, characterised by 
inflammation and include arthritis, rashes, kidney involvement and 
fevers (Schur, 1983; Hardy, 1985). 
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The most common symptom of SLE is inflammation of the synovial 
membrane that surrounds the joints (Schur, 1983). This occurs in 
about 90 percent of sufferers and differs from rheumatoid arthritis in 
that joint deformity is rare. Often accompanying joint involvement is 
inflammation of the tendons and muscles which occurs in about 15 
percent of lupus sufferers. 
The skin is affected in over 70 percent of individuals with SLE (Hardy, 
1985). Rashes may be present on the hands, feet or face and arise from 
inflammation of arterioles. A butterfly rash over the cheeks and nose 
bridge occurs in about 40 percent of patients. About 15 percent of 
individuals have discoid lesions. These are red, blotchy, scaly sores 
that may leave scaring upon healing. 
Inflammation of the kidneys can result in protein and blood in the 
urine and is a significant cause of death in SLE sufferers (Schur, 1983). 
If the membrane that surrounds the lungs becomes inflamed, sharp 
stabbing pains on taking a deep breath may result. Pericarditis occurs 
when the pericardium membrane encasing the heart becomes 
inflamed. The symptoms of pericarditis mimic myocardial infarction 
and include shortness of breath, ankle swelling and breathing 
difficulties after exercise or when lying down. 
Raynaud's phenomenon is similar to frostbite but occurs in the 
absence of cold weather (Blau & Schultz, 1984). It results from 
inflammation of arterioles that supply blood to the fingers and occurs 
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in about 15 percent of sufferers. Sjogren's syndrome occurs in 40 
percent of patients and results from reduced gland secretions. 
Other signs and symptoms of SLE include anaemia, seizures, 
psychoses, damage to the retina, temporary hair loss and mouth 
ulceration. Fevers, light sensitivity (photosensitivity), generalised 
aching and fatigue also are common. Gastrointestinal problems such 
as constipation, diarrhoea, nausea and vomiting are evident in 40 
percent of sufferers (Blau & Schultz, 1984; Hardy, 1985). 
Despite the diversity of SLE symptoms, rarely do individuals 
experience more than five or six of those described above. 
Furthermore, while organs such as the heart and kidneys may become 
involved, the majority of sufferers do not experience such 
complications. Regardless of the symptoms that arise, SLE can be 
debilitating as symptoms disrupt life-style causing sufferers 
considerable psychological distress. 
DISEASE COURSE 
The symptomatology of SLE is characterised by periods of flare and 
remission (Blau & Schultz, 1984; Hardy, 1985). A disease flare 
occurs when symptoms increase in intensity and there is 
inflammation of the affected organs. Remission occurs when 
symptoms become more quiescent and inflammation is reduced. 
Since SLE is a chronic disorder, remission does not necessitate the 
absence of inflammation or symptomatology, rather symptom 
intensity is merely reduced (Hardy, 1985). 
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Since prognosis depends on numerous factors such as the severity 
of the disease, the organs effected, age and response to therapy, it is 
difficult to predict the course of SLE. Improved diagnostic 
strategies and pharmacological management are, however, 
contributing to an increasing survival rate, with the result that life 
expectancy has doubled in the last 20 years (Schur, 1983). In 1953, 
for example, the five year survival rate was less than 40 percent. In 
a 1987 study over 80 percent of individuals were alive nine years 
after diagnosis (Studenski, Allen, Caldwell, Rice & Polisson, 1987). 
Despite an increasing life expectancy and treatment advances, the 
major causes of mortality remain unchanged. These are 
progressive renal failure, central nervous system (CNS) symptoms 
and superimposed infections (Kinash, 1983; Studenski, et al., 1987; 
Wallace & Dubois, 1987). 
Although SLE is sometimes life—threatening, the majority of 
individuals survive well into the sixth decade ( Wallace & Dubois, 
1987). Nonetheless, the prospect of kidney or CNS involvement or 
a poor prognosis remains a concern for many sufferers. 
Occasionally such concerns may disrupt social and occupational 
functioning and cause considerable psychological distress (Hardy, 
1985). 
DIAGNOSIS 
Systemic lupus erythematosus mimics the symptomatology of other 
diseases (Kinash, 1983). For example, it is common for individuals to 
present with evidence of arthritis, but there is no joint deformity 
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when x—rayed. Similarly, chest pains suggesting heart disease may be 
reported, but there are no electrocardiogram abnormalities. •The 
pathogenesis and flaring and remitting course of SLE can make 
diagnosis difficult. Only when symptoms appear then disappear is the 
condition suspected and because symptoms can take years to appear, 
diagnosing the condition also may take years. 
A RA CRITERIA 
In 1971 the American Rheumatism Association (ARA) published 
preliminary diagnostic criteria to clarify the parameters of SLE 
( Wallace & Dubois, 1987). These criteria were revised in 1982 to 
achieve a diagnostic sensitivity and specificity rate of 96 percent 
(Schur, 1983). An individual has SLE if they meet four of the 11 
criteria (Appendix one) and is given a probable diagnosis if they meet 
three. Symptoms need not be present simultaneously and a patient's 
medical history is considered when reaching a diagnosis. It takes an 
average of three years for a patient to meet four ARA criteria ( Wallace 
& Dubois, 1987). 
Despite the high reported sensitivity and specificity of the ARA 
criteria, the taxonomy has several limitations. It excludes important 
signs of SLE such as alopecia (hair loss), Raynaud's phenomena, 
persistent low grade fevers and fatigue. The criteria were derived 
from a small sample of SLE sufferers and from retrospective studies 
( Wallace & Dubois, 1987). The ARA scheme also may eliminate some 
individuals from an 'official' diagnosis, as it does not weight the 
importance of symptoms. For example, individuals could have 
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definitive symptoms such as immunological disorder, antinuclear 
antibodies and a discoid rash but would not be diagnosed with SLE as 
they met only three criteria. 
Since the present study is not concerned with the medical diagnosis of 
SLE, the ARA scheme will be modified for recruiting volunteers. In 
this study, an individual has SLE if they meet (a) three ARA criteria 
and their treating physician has diagnosed SLE, or (b) have 
immunological disorder, antinuclear antibodies and one other ARA 
diagnostic symptom. 
DIFFERENTIAL DIAGNOSIS 
Discoid skin lesions in the absence of subcutaneous symptoms is 
diagnosed as discoid lupus erythematosus (DLE) rather than SLE. 
Discoid lupus is characterised by localised inflammation of the skin, 
often occurring in areas exposed to solar or ultraviolet irradiation. 
This condition is persistent but not life-endangering, although in 
some cases SLE develops (Hardy, 1985). 
A lupus-like syndrome also may be induced by several classes of drug, 
including cardiovascular, antimicrobial, anticonvulsant and 
psychotropic medications (Schur, 1983). Drug-induced SLE differs 
from the idiopathic variety in several ways. It does not favour 
women more than men. Nephritis (inflammation of the kidneys) 
and central nervous system features are not ordinarily present. 
Antibodies to several classes of proteins are less common in 
drug-induced lupus. Finally, false-positive tests to syphilis (ARA 
10 
criteria 10) disappear when the offending drug is withdrawn (Krupp & 
Schroeder, 1987). In about 30 percent of individuals, however, the 
offending medications precipitate the idiopathic condition, suggesting 
some individuals have a pre—existing diathesis for SLE (Harmon & 
Portanova, 1982). 
EPIDEMIOLOGY 
Several studies confirm the incidence of SLE is between 2.6-4.6 per 
100,000 with a prevalence rate of 1 per 6780 (Meddings & Grennan, 
1980; Wallace & Dubois, 1987). The ratio of women to men sufferers is 
reported as 9:1, although this varies with age. Below the age of 15 and 
above 60 this ratio is somewhat lower, with about twice as many 
females suffering from SLE as males. Explanations for the gender 
difference rates include loss of male siblings at birth, environmental 
and hormonal factors. These will be discussed further in the etiology 
section. Reported onset ages range from three months to 87 years, 
however most cases have their onset between 15 and 45 years. The 
average onset age is 28 years for females and 51 years for males. 
Higher rates of SLE have been reported in black Americans, Hispanics, 
Chinese and Indian populations ( Wallace & Dubois, 1987). Racial and 
geographic differences are however a likely consequence of sampling 
strategies and diagnostic practices. Studies comparing black with 
white Americans, for example, report threefold prevalence rates in 
the former group. Yet the prevalence rate for black Africans is 
comparable to that of white Americans. Another explanation for 
racial patterns stems from naturally differing levels of blood 
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constituents. Blacks, for example, have naturally higher levels of 
gamma globulins than whites (Wallace & Dubois, 1987). Differing SLE 
spectrum definitions also explain contrary prevalence rates. 
American studies that use ARA diagnostic criteria may exclude SLE 
sufferers, whereas Asian and Indian definitions are more inclusive 
( Wallace & Dubois, 1987). 
ETIOLOGY 
While the pathogenesis is well documented, less is known about the 
causes of lupus. It is likely, however, that lupus arises from a 
combination of hormonal, genetic and viral causes. These are briefly 
considered below and the interested reader is referred to Wallace and 
Dubois (1987) for an extensive review. 
HORMONAL 
Autoimmune conditions occur more often in women because they 
are more immunologically reactive than men (Talal, 1987). 
Immunologic reactivity is in turn regulated by sex [steroid] hormones. 
This observation was initially made in a species of hybrid mice 
(known as NZB/NZW) that spontaneously develops a syndrome 
analogous to human SLE. De—sexing the mice exacerbates SLE in 
pre—pubertal males but does not effect the disease course of females. 
Administering androgens to females, however, results in a normal 
life span and increases survival rates in mice already afflicted with 
SLE (Talal, 1987). 
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The regulation of immune processes by sex hormones is only possible 
if lymphocytes have androgen and oestrogen receptor sites. These 
exist on T—lymphocyte suppressor cells found in the thymus gland. 
Here both androgens and oestrogens decrease their reactivity. 
Receptor sites also exist on suppressor cells in the spleen and lymph 
organs. Here immunological reactivity is decreased by oestrogens and 
increased by androgens. Sex hormones also regulate interleukin-2 
levels and thus killer and suppressor cell activities. The functions of 
interleukin-2 are diminished by oestrogens and increased by 
androgens (Bhalla, 1989). 
GENETIC 
The inheritance of SLE is associated with the sixth chromosome of 
human cells which contains a region that controls immunological 
functioning. This area is generally known as the major 
histocompatibility complex (MHC) and in humans as the human 
leukocyte antigen (HLA) region. The HLA region has several 
subregions that are genetically determined. In the autoimmune 
disease rheumatoid arthritis (RA) for example, 75 percent of sufferers 
inherit a subregion known as HLA—DRw4 and occasionally the 
disease is associated with the DRw3 and DRw5 regions. Similar 
studies with SLE patients have been less successful in identifying 
associated HLA regions. DRw2 has been identified in 53.7 percent of 
SLE patients and 26.1 percent of controls and Drw3 is reported in 45.1 
and 20.4 percent of SLE and control subjects respectively (Blau & 
Schultz, 1984). 
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VIRAL 
Viral ribonucleic acid (RNA) from myoviruses and paramyxoviruses 
have been consistently observed in SLE patients. High myoviruses 
and paramyxoviruses levels do not, however, imply a viral etiology as 
corticosteroid treatments suppress immune functioning making 
patients more susceptible to secondary viral infections (Blau & 
Schultz, 1984). 
There remains, however, a general belief that viral agents are 
somehow active in SLE (Talal, 1987). This stems from several 
similarities between SLE and acquired immune deficiency syndrome 
(AIDS). These include the production of antinuclear antibodies, lower 
interleukin-2 levels, fewer natural killer cells, increase gamma 
globulin levels and depressed B—lymphocyte suppressor cell 
functioning. 
TREATMENT 
Despite the progress medicine has made toward understanding the 
underlying symptomatology of SLE, practitioners remain 
disadvantaged when treating patients (Decker, 1983). The etiology of 
SLE is unknown and thus treatment can only focus on reducing 
inflammation and treating symptoms as they arise, altering 
medications as symptoms abate, intensify or change altogether (Blau 
& Schultz, 1984). The treatment of SLE is, therefore, highly 
individualistic. 
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PHARMACOLOGICAL 
Prior to the 1940's no drug or class of drug was helpful in treating the 
symptomatology of SLE. By the mid 1970's several classes of drug, 
including antimalarials, corticosteroids, immunosuppressants and 
non-corticosteroid anti-inflammatories had proved useful in 
managing disease symptomatology (Hughes, 1988). 
Antimalarials 
Antimalarials came into use in SLE after their effectiveness against 
discoid lupus erythematosus had been observed. Although the 
mechanism of these drugs is unknown they inhibit antigen-antibody 
(ANA) formation, reduce light filtration by the skin (about 30 percent 
of disease sufferers exhibit photosensitivity) and inhibit viral 
replication (viruses have been implicated in the etiology of SLE). 
These drugs also reduce inflammation (Hughes, 1982). The most 
widely used antimalarials are hydroxychloroquine (Plaquenil) and 
mepacrine (Quinacrine). 
There are, however, some side-effects that restrict the extensive use of 
antimalarials. For example, there is a high incidence of 
gastrointestinal disturbance, with nausea and vomiting, which is 
associated with all antimalarials. Other side-effects include 
premature greying of the hair, blotchy skin, convulsive seizures, 
myopathy (muscle weakness) and skin rashes. The most serious 
side-effects involve vision, usually blurring when the medication is 
started and a 'halo' effect around bright lights. Furthermore, deposits 
of these drugs collect in the cornea of the eye, causing tunnel vision 
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and possibly [irreversible] blindness (Hughes, 1982). Many of the 
harmful side-effects from antimalarials are avoidable, through 
careful monitoring and withdrawing the medication at the first signs 
of side-effects. Additionally, regular visits to an optometrist can 
reduce the incidence of visual impairments (Hughes, 1982). 
Corticosteroids 
Corticosteroids are the most widely used drug in the treatment of SLE. 
While their mechanism is speculative, they are documented to 
decrease T cell numbers, interleukin-2 levels and natural killer cell 
activity (O'Leary, 1990). Like the antimalarials, however, there are 
several side-effects from prolonged use or high doses of 
corticosteroids. These include slowed hair growth, osteoporosis, 
cataracts, decreased concentration span, heightened senses, masking of 
infections, weight gain, elevated blood pressure, emotional problems, 
psychosis and diabetes mellitus to name a few (Blau & Schultz, 1984; 
Hughes, 1982; Sutton, Navarro & Stevens, 1984). 
Immunosuppressants 
Immunosuppressants directly suppress immune regulation via 
decreasing lymphocyte production and interleukin levels. Their 
side-effects include nausea and vomiting. Since 
immunosuppressants suppress the immune functioning, they 
increase the risk of secondary infections such as pneumonia. 
Immunosuppressants also are known to interact with several 
common drugs, including alcohol, aspirin and some tranquillisers to 
cause other side-effects (Blau & Schultz, 1984). 
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Non-Corticosteroid Anti-Inflammatory Agents 
Mild cases of SLE may be treated with aspirin (acetylsalicylic acid). 
Aspirin contains an analgesic (pain reliever) and antipyretic (to reduce 
fever) and effectively reduces inflammation and fevers associated 
with SLE (Blau & Schultz, 1984). Side-effects from aspirin are often 
less severe than those of the other medications mentioned above and 
are often controllable. The risk of gastric side-effects, for example, 
may be overcome by administering the drug along with buffer 
solutions such as Alka-Seltzer (Hughes, 1982). There also are 
stronger forms of aspirin designed to manage disease flares. These are, 
however, used more cautiously as the risk of serious side-effects is 
greater. Possible side-effects include allergies, liver complications, 
intestinal bleeding and visual difficulties. 
Summary 
With the exception of non-corticosteroid anti-inflammatory agents 
and low doses of corticosteriods, pharmacological treatments for SLE 
can be aggressive and cause substantial side-effects. Since the 
side-effects from medication can be more debilitating than the 
symptom they treat, it is not uncommon for individuals to experience 
considerable social and psychological problems. 
PSYCHOLOGICAL 
In Australia, self-help groups and Lupus Societies provide the major 
sources of psychological management for individuals with SLE 
(Hardy, 1985). Individuals also may receive private counselling or 
psychological assessments as part of ongoing medical care. 
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Internationally there have been few published studies that evaluate 
the efficacy of psychological interventions with SLE sufferers. This is 
due to the limited understanding of how the disease effects the 
psychological adjustment of sufferers. Investigations of the social and 
psychological consequences of SLE would provide the foundations for 
intervention studies. 
MEDICAL ASPECTS AND PSYCHOLOGICAL ADJUSTMENT 
The disease course of SLE may effect the social and psychological 
adjustment of sufferers in a variety of ways. In about 15 percent of 
sufferers, symptoms may directly cause psychopathology. For 
example, hypertension can induce psychotic states. The waxing and 
waning course of SLE may impede social and occupational 
functioning and prolonged disease flares may erode social support and 
self—efficacy beliefs. Symptoms that cause disfiguration such as facial 
rashes may precipitate depressive states. Side—effects from treatment 
such as weight gain also cause distress and corticosteroids can directly 
precipitate depression. Finally, because it takes an average of three 
years to diagnose SLE, individuals experience considerable stress in 
not knowing what they are suffering (Hardy, 1985). 
1.1.1 SUMMARY 
This chapter provided a medical overview of SLE. The information 
presented provides the foundations for understanding literature 
reviewed in the next section. It also highlights the relationship 
between medical factors, social and psychological adjustment. In 
particular, symptomatology, diagnostic issues and treatment all can 
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contribute to social and psychological adjustment problems in 
sufferers. 
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Chapter Two 
Psychological Adjustment and 
Systemic Lupus Erythematosus 
20 
2.0.0 OVERVIEW 
Chapter one established that immune system dysfunction is 
responsible for the symptomatology of SLE, which in turn can cause 
physical disability, psychosocial disruption and psychological distress 
in sufferers. The next section reviews research on the psychological 
and social factors related to SLE. In sections the review includes 
studies with other chronic illnesses, as there was insufficient research 
with SLE sufferers. 
Consistent with other research, the chapter conceptualises factors 
affecting chronic illness as either social, personal or disease outcome 
measures (Hooker, Monahan, Shifren & Hutchinson, 1992; Revenson 
& Majerovitz, 1991). Social resources are those variables influenced by 
external events, they include stress, social support and social 
networks. Personal resources are mediated by individuals' perceptions 
and include self—efficacy and coping. Outcome measures are the 
consequences of chronic illness and include physical disability, 
psychosocial disruption and psychological distress (Husaini & von 
Frank 1985). 
2.1.0 SOCIAL RESOURCES 
Stress, social support and social networks are important social 
resources influencing illness outcome. This section reviews how 
stress effects immune functioning, issues relevant to measurement 
and the role of stress in SLE. The section then focuses on social 
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support and social networks, relevant measurement issues and how 
they mediate disease outcome variables. 
2.1.1 STRESS 
A concise and informative definition of stress is provided by Cox 
(1987). 
"Stress, it is argued, can only be sensibly defined as a perceptual 
phenomenon arising from a comparison between the demand 
on a person and his ability to cope. An imbalance in this 
mechanism, when coping is important, gives rise to the 
experience of stress, and to stress response. The latter 
represents attempts at coping with the source of stress. Coping 
is both psychological (involving cognitive and behavioural 
strategies) and physiological. If normal coping is ineffective, 
stress is prolonged and abnormal responses may occur. The 
occurrence of these, and prolonged exposure to stress per se, 
may give rise to functional and structural damage. The 
progress of these events is subject to great individual 
variation." 
(p. 25) 
STRESS AND IMMUNE FUNCTIONING 
Immune cells have receptors for stress related hormones such as, 
beta-endorphins, enkephalins, corticosteroids and catecholamines 
(Bhalla, 1989; O'Leary, 1990). These hormones affect immune 
functioning in different ways. For example, beta-endorphins enhance 
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overall immune functioning, while enkephalins stimulate 
T—lymphocyte and natural killer cell activity. Catecholamines 
(epinephrine and norepinephrine) cause the release of lymphocytes 
from storage and increase natural killer cell activity. Corticosteroids 
reduce T—lymphocyte numbers, impair interleukin-2 production and 
decrease natural killer cell activity. 
Immune cells also manufacture hormones that influence CNS 
functioning. For example, interleukin-1 and interleukin-2 act on the 
hypothalamus and pituitary gland to raise adrenocorticotrophic 
hormone levels. Other CNS hormones synthesised by immune cells 
are substance P, beta—endorphins, enkephalins, corticosteroids and 
catecholamines (O'Leary, 1990). 
Another line of inquiry investigates the relationship between 
exposure to acute or chronic stress and changes in immune 
parameters. Immune system responsiveness to acute stress was 
investigated by Zakowski and associates (Zakowski, McAllister, Deal & 
Baum, 1992). Following a stressful film, lower lymphocyte numbers 
were observed in 20 healthy men. This change was evident 15 
minutes after stress exposure and lasted for about 90 minutes. A two 
week follow—up, however, reported that temporary lymphocyte 
alterations did not increase illness susceptibility. 
Individuals exposed to chronic stressors, such as carers of Alzheimer's 
disease patients, also have impaired immune functioning. 
Kiecolt—Glaser and associates (Kiecolt—Glaser, Glaser, Shuttleworth, 
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Dyer, Ogrocki & Speicher, 1987) found care givers had lower 
helper:suppressor cell ratios, T lymphocyte and T helper cell numbers 
than the comparison group. Although differences between natural 
killer cells and T suppressor cell numbers were not apparent, carers 
had higher titers to Epstein—Barr virus suggesting poor immune 
reactivity to antigens. 
Since psychological variables can moderate stress responses, they also 
should mediate immune functioning and subsequent disease 
outcome. In one study, only individuals with low social support had 
impaired immune functioning (Baron, Cutrona, Hicklin, Russell & 
Lubaroff, 1990). This relationship was not mediated by either 
depression or stressful life events. However, a suitable comparison 
group was absent and social support levels were determined by a 
median split of the sample. Median splits have been demonstrated to 
confound social support with stress levels (see Thoits, 1985 for a 
review). 
Social support levels also can mediate changes in immune 
functioning resulting from examination stress (Jemmont & Magloire, 
1988). Salivary antibody (IgA) levels were assessed prior to, during and 
post examination time in 15 university students. Antibody levels 
were lowest during exam times and highest 14 days after exams 
finished. Students with higher social support had the lowest IgA 
levels and were in better health than the low support group. However 
changes in diet and sleep typically accompany academic stress, so these 
may have contributed to immune alterations (O'Leary, 1990). 
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Personal resources such as locus of control buffer the relationship 
between daily hassles and immune functioning (Kubitz, Peavy & 
Moore, 1986). Using a sample of individuals with either high or low 
reported hassle levels, no significant differences in IgA titers were 
evident. An internal locus of control, however, was associated with 
lower IgA levels. This suggests it is perceived control that effects 
immune functioning rather than stress. Nevertheless only one 
percent of IgA protein becomes anti-body reactive upon encountering 
an antigen making the index an unreliable assessment of immune 
functioning (O'Leary, 1990). 
Another personal resource, self-efficacy also mediates the relationship 
between stress and immune functioning. Individuals provided with 
training to enhance self-efficacy reported less stress and showed 
increases in immune efficiency as measured by B-lymphocyte, T-cells 
and interferon levels (Wiedenfeld, O'Leary, Bandura, Brown, Levine 
& Raska, 1990). Although the study controlled for confounders of 
immune functioning, such as diet, menstrual cycle and circadian 
rhythms, its limitation was the exclusion of a suitable comparison 
group (O'Leary, 1990). 
The cited studies suggest the immune system is highly reactive to both 
acute and chronic stress. They also suggest social resources (e.g., high 
social support) and personal resources (e.g., self-efficacy and locus of 
control) mediate the stress response and hence immune functioning. 
Nevertheless, it remains to be demonstrated how short-term immune 
alterations influence the disease process. 
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MEASUREMENT 
The previous section discussed the relationship between stress and 
immune functioning without regard to the controversy regarding 
stress measurement. The next section distinguishes between the 
diferent approaches and outlines the rationale for the measurement 
strategy adopted in the present study. 
There are three approaches to measuring stress. 	 The first 
conceptualises stress in terms of [physiological] responses such as heart 
rate and blood pressure. Measuring the physiological concomitants of 
stress arose from Selye's notion of a General Adaptation Syndrome 
(GAS; Cox, 1987). The GAS has three stages. During the first stage the 
body demonstrates changes characteristic of stress such as an 
accelerated heart rate and increased blood pressure. This phase is 
accompanied by decreased resistance to disease. In the second stage the 
body adapts to prolonged stress and resistance to disease increases. The 
final stage is characterised by exhaustion. In this stage the body's 
resistance to disease decreases and if stress is prolonged the organism 
becomes il and may die. 
Physiological response measures are not widely used in studies of 
chronic ilness as they confound disease symptomatology with signs of 
stress. They also do not correlate with the three GAS stages, suggesting 
other factors mediate stress responses (Cox, 1987). 
The second approach measures stress as a stimulus. This model 
assumes that external events have the potential to cause strain or 
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stress within a person. Stimulus models typically use either life event 
or daily hassle inventories as stress measures. Life events are major 
social changes that demand adaptation from an individual. Examples 
include divorce, death of spouse and birth of a child. Hassles are 
ongoing problems that cause social disruption. They include noisy 
neighbours and work stress (Chamberlain & Zika, 1990). The life 
events and daily hassle stress measures are the most popular 
approaches in chronic illness research because they quantify stress and 
are easily administered. 
The final approach uses an interactional paradigm, assessing stress as a 
stimulus and a response (Cox, 1987). Research adopting this approach 
also measures variables that moderate the stress approach such as 
self—efficacy and coping skills. The distinctions between the different 
measurement approaches are however becoming less clear as 
researchers routinely measure a range of behavioural and cognitive 
factors that effect stress reactions. Whilst the stimulus approach is 
adopted in the present study, it is considered in the wider context of 
other cognitive and behavioural factors. 
LIFE EVENTS AND DAILY HASSLES 
Since the stimulus approach is less likely to confound disease 
symptomatology with stress, it is used widely in chronic illness 
studies. Two extensively used measures are life event and daily hassle 
inventories. This section provides a description of each assessment 
approach and a discussion of their relative merits. 
27 
LIFE EVENTS 
These are assessed by assigning standardised weights for the amount of 
readjustment a given event requires. The weights are summed to 
yield an index of life change or stress. Higher life change scores are 
associated with an increase in psychological distress, psychosocial 
dysfunction and physical symptoms (see Felner, Farber & Primavera, 
1983 for a review). Correlations between life change and disease are 
however small, ranging from .10 to .20 (Felner, et al., 1983). This 
suggests that other factors such as personal resources mitigate the 
relationship between stress and disease (Feiner et al., 1983). 
DAILY HASSLES 
A similar methodology assesses daily hassles as antecedent to disease 
outcomes. This approach has, however, notable differences to the life 
event method. It does not assume standardised stress scores, rather 
respondents estimate the amount of stress and pleasure (uplift) an 
event provides (Chamberlain & Zika, 1990). 
Studies measuring both life events and daily hassles suggest the latter 
approach is a better predictor of disease outcome ( Weinberger, Hiner & 
Tierney, 1987; Chamberlain & Zika, 1990). Daily hassles and uplifts 
account for more variance in concurrent and subsequent disease 
outcomes than do stressful life events. Daily hassle and uplift 
inventories also have stronger test—retest reliabilities for the reported 
number and rated severity of events, when compared with life event 
inventories (Chamberlaine Sr Zika, 1990). For the aforementioned 
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reasons the daily hassle and uplifts approach was adopted in the 
present study. 
LIFE EVENTS, HASSLES AND SLE RESEARCH 
Only a few studies document the impact of stress on SLE and they do 
not typically measure variables mediating the stress/disease outcome 
relationship. The earliest was concerned with the ways stress 
contributed to the onset of SLE. Otto and Mackay (1967) defined stress 
as "the conscious experience of tension— that is, depression, 
frustration, anger or anxiety, or undue physical strain" (p.489). 
Twenty SLE volunteers and a comparison group of women who had 
an accidental haemorrhage during pregnancy were matched for age, 
sex and socioeconomic status. Stressful life events were assessed via a 
structured interview. Significantly more SLE (100%) than control 
(60%) subjects reported that stress preceded the onset of their 
condition. A further 65 percent of SLE patients reported that life 
events also had preceded a disease exacerbation. The most frequently 
reported life events involved interpersonal relationships for both SLE 
and control subjects. 
The Otto and Mackay study has several methodological problems that 
detract from the value of its findings. The rater was not 'blind' to the 
groups' diagnoses and individuals recalled stressful life events that 
occurred as long as 15 years prior to disease onset. The average time 
since diagnosis was 6.5 years for SLE sufferers and 3.5 years for controls 
making the memory of the events surrounding illness onset more 
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reliable for the latter group. Finally, the researchers confound their 
stress and disease outcome measures. 
More recent research has focused on the notion that chronic illness 
leads to elevated stress levels and this exacerbates disease flares. In one 
study, 80 percent of SLE volunteers reported they felt stress preceded 
disease flares and aggravated their illness (Laing, Rogers, Larson, 
Eaton, Murawski, Taylor, Swafford & Schur, 1984). This relationship 
was further investigated in a prospective study using life event 
methodology (Rimon & Kronqvist, 1988). Over a 3.5 year period, 50 
percent of SLE sufferers reported one or more stressful life events 
preceded a disease flare. The most frequently reported events included 
loss of a spouse, serious illness of a close family member, marital crisis 
and financial difficulties. Although this study used a prospective 
design, a comparison group was not included. Thus, it is unclear 
whether life events occur more often in SLE patients than in the 
general population. The study also did not include personal resource 
measures such as self—efficacy and coping, to determine whether these 
mitigate stress levels and hence disease outcomes. 
Using a daily hassles measure, Wekking and associates ( Wekking, 
Vingerhoets, van Dam, Nossent & Swaak, 1991) investigated whether 
hassle levels were higher in SLE than RA sufferers. Whilst no 
differences in stress levels were apparent, stress was related to physical 
and psychosocial status for SLE but not RA sufferers. This study also 
has significant methodological problems. For example, the sample 
size was small and the assumptions of MANOVA were not met. The 
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effects of uplifts on well—being were not considered. A fatigue or 
boredom effect also was present, as subjects failed to complete the 
measures across consecutive assessment occasions. Furthermore, 
inclusion of a healthy control group would have allowed conclusions 
regarding whether a diagnosis SLE or RA in itself, leads to elevated 
hassle levels. 
Given the methodological problems of the studies cited above, it 
remains to be established whether individuals with SLE experience 
greater stress levels than other chronically ill people or the general 
population. How social and personal resource variables mitigate the 
stress disease relationship also has not been reported. The present 
study adopts the daily hassle and uplift approach, to investigate group 
differences in stress and whether these measures predict disease 
outcomes. 
SUMMARY 
Immunological studies demonstrate hormonal links between the 
immune and central nervous systems and psychological studies 
suggest that immune changes coincide with both acute and chronic 
stressors. Immune changes are however highly individualistic and 
may either increase or decrease upon exposure to stress. 
Measuring stress as a stimulus, the reviewed studies suggest life 
events and daily hassles precede the onset of SLE and subsequent 
disease flares. These findings are however unimpressive when their 
methodological limitations are considered— most are retrospective, 
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uncontrolled or include only one comparison group. A two 
comparison group design is necessary for determining whether high 
stress levels are specific to SLE. There also is a need to investigate if 
stress predicts disease outcome when other social and personal 
resources are incorporated into the model. 
2.1.2 SOCIAL NETWORKS AND SOCIAL SUPPORT 
Research has differentiated social networks from the functions of 
social support, though the terms are often used interchangeably. 
Social networks (or social embeddedness) can be divided into 
structural and interactional parameters (Cohen & Wills, 1985). 
Structural parameters include the number of network members and 
embeddedness in social organisations. Interactional dimensions 
include network composition (e.g., the relative number of friends, 
co—workers or relatives) and contacts between network members. 
Social (or functional) support refers to a more specific idea than 
network. Its assessment involves identifying those aspects of social 
relationships that promote psychological and physical well—being. 
These include belonging, instrumental, self—esteem and informational 
aid (Cohen Sr Wills, 1985). Belongingness (also known as diffuse 
support and social companionship) is spending time with others in 
recreational or leisure activities. This may reduce distress by, for 
example, distracting individuals from worrying events or enhancing 
feelings of affiliation. Instrumental (or material or tangible) aid 
involves the provision of actions or materials, such as assistance with 
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work or providing money to pay bills. Receiving instrumental 
support may reduce distress by allowing the individual more time for 
other activities. Self—esteem (or emotional or expressive) support 
refers to communications or demonstrations that a person is valued. 
This promotes feelings of self—esteem and reduces vulnerability to 
stress. Informational (or appraisal) assistance includes the provision 
of advice and feed—back, that may aid in coping. It is likely that 
information support reduces stress by helping individuals to 
understand or define their problems.I 
Since the distinction between social support and network has 
important assessment implications and explains contrary research 
findings, it is maintained throughout this text. The term 'social 
relationships' will describe the characteristics of social networks and 
support. 
MODELS 
Social relationships may influence health in a variety of ways. Social 
resources may be mobilised only when an individual is, for example, 
ill or under stress. This is the buffering model of support and is 
shown statistically whenever an interaction between illness [or stress] 
and support is •found (Cohen & Wills, 1985; Thoits, 1982). The 
peripheral model of support is a variant of the buffering hypothesis 
(Henderson, 1984; Cohen & Wills, 1985). It asserts that support 
influences health by helping with the recovery from an event after it 
' Although topologies distinguish support functions, research suggests they correlate 
(Cohen, Mermelstein, Kamarck & Hoberman, 1985). 
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has occurred. Evidence for the peripheral model also comes from a 
statistical interaction between support and stress. 
Social relationships also may have a beneficial effect irrespective of 
whether an individual is ill or experiencing a stressful event. 
Evidence for this model comes from a statistical main-effect for 
support without the presence of an interaction effect (Cohen & Wills, 
1985; Thoits, 1985). There is research to support both the main and 
buffering models and they are not mutually exclusive (Cohen & Wills, 
1985). 
THE LINK BETWEEN SOCIAL RELATIONSHIPS AND DISEASE 
OUTCOMES 
Whether social relationships have a main- or buffering-effect, they 
protect individuals from stress and reduce the risk of physical and 
psychological ill health (Wallston, Alagna, DeVillis & DeVillis, 1983; 
Cohen & Wills, 1985) How social relationships influence health 
requires clarification. Proposed mechanisms include promoting 
healthy life styles, coping assistance and influencing physiological 
processes and therefore possibly disease outcomes. 
SOCIAL NETWORKS 
Social networks promote generalised feelings of psychological 
well-being that protect individuals from ill health. They provide 
members with a sense of predictability and stability, norms for 
behaviour, encourage positive affect and enhance feelings of 
self-worth and belonging (Cohen & Wills, 1985). Establishing and 
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maintaining social network ties is mediated by personal resources such 
as self-efficacy and the personality dispositions of network members 
(Monroe & Steiner, 1986). 
SOCIAL SUPPORT 
Social support may influence disease outcomes by promoting 'coping 
assistance' (Thoits, 1986). Support functions help distressed 
individuals to cope by reinforcing their efforts to change the meaning, 
feelings, or management of stressful circumstances. Tentative 
evidence for this hypothesis comes from the noted similarities 
between topologies of coping and support. For example, 
problem-focused coping and instrumental support, both consist of 
attempts to remove or alter threatening environmental circumstances. 
Similarly, emotion-focused coping and emotional support, attempt to 
alter negative feelings that accompany distress. 
Social support also may influence physiological reactions to stress. For 
example, one study measured support as a coping strategy and found it 
predicted 33 percent of natural killer cell activity (Levy, Herberman, 
Whiteside, Sanzo, Lee & Kirkwood, 1990). A study with Japanese 
living in Hawaii found low social support levels predicted high blood 
pressure independently of other risk factors such as smoking and 
alcohol consumption (Joseph, 1981 in Berkman, 1984). Social support 
also may moderate health related behaviours such as seeking medical 
advice, smoking, alcohol consumption and blood pressure (Levy et al., 
1990). Finally, social support promotes adherence to complicated 
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medical regimes and life style changes (Gottielb & Green 1984; 
Zimmerman & Connor, 1989). 
• MEASUREMENT ISSUES 
Social network measures can be divided into specific and global 
indices. Specific assessments ask about a single parameter of network 
structure, such as the number of significant others who potentially 
provide social support. Global measures simultaneously index 
connections with, for example, friends, neighbours and community 
organisations (Cohen & Wills, 1985). Network size is a better predictor 
of the main—effect model than are global measures (Cohen & Wills, 
1985; Heitzmann & Kaplan, 1988). 
Social support measures also can be distinguished along the 
global/specific dimension. Global measures ask about several 
dimensions of social support such as emotional, informational and 
instrumental aid. Specific measures ask about one functional aspect of 
social support, such as the context in which emotional support was 
received .2 
Global social support measures usually yield support for the buffering 
model (Cohen & Wills, 1985). Specific measures only show a 
buffering effect if they coincide with support requirements. For 
example, instrumental support relieves financial stress. 
2 This is also known as enacted support (Barrea, 1986) 
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Based on empirical findings (see Heitzmann & Kaplan, 1988 for a 
review), the present study uses a specific social network measure to 
investigate whether individuals with SLE have adequate access to 
potential sources of social support. A global measure of social support 
is also included to determine whether SLE sufferers have levels of 
functional support comparable to healthy and other chronically ill 
people. The main- and buffering- effect models are not investigated, 
as longitudinal data that control for pre-existing social support and 
stress levels are required (Thoits, 1985; Cohen & Wills, 1985). 
SOCIAL RELATIONSHIPS AND AUTOIMMUNE DISEASE 
RESEARCH 
Since the role of social relationships in the outcome of SLE has not 
been reported, the following discussion reviews recent research with 
other autoimmune diseases. Although depression is the outcome 
measured in most studies, several also consider disability and pain 
measures. 
A study of multiple sclerosis (MS) sufferers found individuals with a 
progressive condition had larger social networks than persons with a 
relapsing-remitting disease course (Wineman, 1990). This finding 
suggests network size grows as disability levels increase and 
individuals rely on significant others for self-care. Whether social 
network members were potential sources of social support also was 
investigated. Perceived unsupportiveness from network members 
predicted depression in individuals with a progressive disease course. 
This finding was independent of demographic factors such as age, sex 
and socioeconomic status. Since the Wineman study was 
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cross—sectional, the possibility that depression limited access to social 
network members cannot be excluded. 
The efficacy of the buffering and main effect models was examined 
prospectively by Brown and associates (Brown, Wallston & Nicassio, 
1989). Rheumatoid arthritis sufferers completed questionnaires asking 
about emotional support, network size, depression, disability and pain 
on three assessment occasions spanning 18 months. Low levels of 
emotional support, but not the number of network members, were 
associated with elevated depression scores. This relationship was 
independent of pain severity, disability and demographic factors such 
as age and education level. Emotional support also interacted with 
pain severity. Individuals with high pain and low social support were 
more depressed than people with high social support and pain levels. 
This interaction was only present in a cross—sectional analysis of the 
data and not longitudinally. Furthermore, a path analysis of the data 
suggested that low social support levels resulted in depression which 
in turn decreased social support levels. This latter finding 
demonstrates how depression can confound social support levels. 
Another study with 149 RA sufferers found that baseline social support 
levels predicted the severity of depression 15 months later (Fitzpatrick, 
Newman, Archer & Shipley, 1991). This finding was independent of 
initial depression and social support levels. This study used The 
Interview Schedule for Social Interaction which confounds network 
size with functional support, so it is not clear whether social 
relationship have a main or buffering effect. 
38 
A different research strategy looks at the positive and negative effects 
of social relationships (Revenson, Schiaffino, Majerovitz & Gibofsky, 
1991). Revenson et al. found positive support exchanges predicted 
lower depression levels, while negative exchanges predicted high 
depression levels. The interaction between support and depression 
levels suggested that the positive aspects of support were not cancelled 
out by negative transactions. The highest depression levels were 
apparent in RA sufferers with high number of negative transactions 
and few positive social supports. A limitation of the Revenson et al. 
study is stress was not considered as covariate of social support 
satisfaction. 
Social support and social networks can influence disease outcomes in 
individuals with MS and RA. This occurs through embeddedness in 
social networks and through the functional aspects of social support. It 
also appears that only positive social support exchanges are beneficial 
to psychological well—being. How personal resources, such as 
self—efficacy and coping strategies, interact with social support to 
predict disease outcomes has not been reported. 
SUMMARY 
Studies suggest that high levels of social support protect chronically ill 
individuals from depression, disability and pain. Because these 
studies use.correlational designs, it is not clear whether social support 
and social networks are similar in chronically ill individuals and 
healthy controls. This question is fundamental to SLE research, as 
there have been no published studies on social support and networks 
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of sufferers. How social networks and support interact with personal 
resources also is unclear. For example, individuals with high 
self-efficacy may better mobilise support networks and thus minimise 
the impact of stress on disease outcome. 
2.2.0 PERSONAL RESOURCES 
Personal resources are those variables that are influenced by 
perceptions, they include self-efficacy and coping strategies. The next 
section reviews Bandura's notion of self-efficacy and the factors that 
promote efficacy beliefs. The limitations of self-efficacy theory are 
considered and a wider definition of the construct adopted. The 
operationalisation of self-efficacy is discussed, as well as how it differs 
from related personal resources. Finally, how self-efficacy interacts 
with autoimmune diseases such as SLE is considered. The second part 
reviews the Lazarus and Folkman (1984) coping model and those 
studies investigating coping in autoimmune diseases. 
2.2.1 SELF-EFFICACY 
Bandura and associates (Bandura, O'Leary, Taylor, Gauthier & Gossard, 
1987; Bandura, Cioffi, Taylor, Brouillard, 1988) assert both efficacy and 
outcome expectations mediate aspects of health behaviour. 
Self-efficacy expectations are individuals' beliefs about their capability 
of performing a specific behaviour in a given situation (Bandura, 
1977). Outcome expectations are individuals' estimates that a given 
behaviour will lead to a specific outcome. The distinction between 
efficacy and outcome expectation can be clarified using an example. 
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Individuals may be sure that a particular slimming plan will reduce 
weight (outcome expectancy) but lack the confidence they can 
persevere with the diet (self—efficacy). 
Integral to self—efficacy theory is the concept that expectations vary on 
magnitude, strength and generality (Bandura, 1977). Magnitude refers 
to the ordering of tasks by difficulty level. Given a hierarchy of tasks, 
persons with low magnitude expectations can perform only the 
simpler tasks. While individuals with high expectations feel they can 
complete most tasks. Strength is an individual's probability estimate 
of completing a task. Generality is the extent to which efficacy 
expectations generalise beyond a particular situation to other 
situations. For example, abstinence from alcohol achieved as an 
inpatient may not continue upon release from hospital. 
Efficacy expectations develop from performance accomplishments, 
vicarious experiences, verbal persuasion and emotional arousal 
(Bandura, 1977). Most important for the development of efficacy 
expectations are performance accomplishment or learning from 
personal experience. Mastery of a difficult or feared task not only 
increases efficacy expectations, but also promotes skills for coping with 
problematic situations. Vicarious experiences are derived from the 
observations of other's successes and failures on a task and is 
analogous to behavioural modelling. To observe an individual 
successfully complete a task does not, however, ensure personal 
success on one's first or later attempts at the same task. For these 
reasons, vicarious experiences are less important to the development 
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of efficacy expectations than performance accomplishments. In verbal 
persuasion individuals are instructed that they can master a task. 
Since success or failure has not been personally experienced, verbal 
persuasion contributes only moderately to the formation of efficacy 
expectations. The final source of efficacy information comes from 
emotional arousal. Stressful situations can cause anxiety and 
depression that may impede an individuals task performance and 
lower efficacy expectations. 
THEORY REFINEMENTS 
It seems appropriate to modify self-efficacy theory given recent 
empirical findings. Bandura (1978) maintains it is the expectation that 
behaviour cannot be sustained that mediates task performance. 
Overwhelming evidence suggests, however, that it is outcome 
expectations that mediate self-efficacy beliefs (e.g., Maddux, Sherer & 
Rogers, 1982; Marzillier & Eastman, 1984; Wang & Richarde, 1988). 
This can be illustrated by a hypothetical situation requiring a 
non-phobic individual to perform two identical tasks involving 
picking up a snake. In one task the snake is harmless and in the other 
poisonous. It is likely that self-efficacy beliefs will differ for the tasks 
(higher for the harmless than the poisonous snake) and these 
variations arise from the different outcome expectations. 
The predictive validity of self-efficacy expectations also have been 
questioned. Investigations consistently demonstrate that past conduct 
predicts future behaviour more accurately than self-efficacy 
expectations (e.g., DiClemente Prochaska & Gibertini, 1985; Godding & 
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Glasgow, 1985), though this varies across different individuals and 
situations (Garcia, Schmitz & Doerfler, 1990). In fact, when past 
behaviour is statistically controlled the association between efficacy 
and future behaviour is not statistically significant (Garcia et al., 1990). 
Although Bandura (1978) acknowledges dispositional influences, 
situational factors are considered the primary mediators of 
self—efficacy. Empirical research suggests, however, that both 
dispositional and situational factors mediate self—efficacy expectations. 
When a situation is ambiguous, dispositional self—efficacy expectations 
are the best predictors of performance. If circumstances are clearly 
defined then task—specific ratings best predict behaviour ( Wang & 
Richarde, 1988). 
Psychometric difficulties also pervade the assessment of self—efficacy. 
The validity of self—efficacy ratings comes from their correlation with 
performance measures (Bandura, 1982). This logic has several 
problems. Ratings may be reactive due to the close temporal proximity 
of self—efficacy and performance assessments. The identical nature of 
efficacy and performance tasks also may lead to measurement 
redundancy. Finally, the high correlations between efficacy and 
performance assessments may be mediated by other factors such as 
self—esteem (Kazdin, 1978). 
Self—efficacy theory requires some conceptual revisions, given its 
theoretical and methodological limitations. Self—efficacy is a cognitive 
construct influenced by outcome expectations and individuals' 
previous performance accomplishments. In new situations 
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dispositional self-efficacy expectations influence performance. The 
resulting outcome may modify dispositional efficacy expectations and 
allow individuals to predict their performance on subsequent [similar] 
tasks. 
The aforementioned empirical modifications to self-efficacy theory 
have measurement implications. Since efficacy and outcome 
expectancies are highly correlated, this eliminates the need for separate 
assessments. In addition, dispositional measures predict a wider range 
of behavioural outcomes and allow comparisons between studies. The 
present study uses a dispositional measure for assessing whether SLE 
sufferers have lower self-efficacy and outcome expectations. 
RELATIONSHIP TO OTHER PERSONAL RESOURCES 
The concise operationalisation and measurement of self-efficacy 
depends on conceptual clarity. It is, therefore, necessary to distinguish 
self-efficacy from related personal resources. Health locus of control 
refers to individuals' attributions of whether their health is controlled 
by internal or external factors, whereas self-efficacy pertains to 
behavioural expectations ( Wallston, Wallston, Smith & Dobbins, 
1987). Internally oriented individuals have generalised expectations 
that their health is dependent on personal behaviour. Externally 
directed persons believe illnesses are unrelated to personal behaviour. 
Locus of control can interact with self-efficacy in different ways 
(Strecher, DevIllis, Becker & Rosenstock, 1986). In a situation where 
control is possible, a person with high self-efficacy expectations copes 
with distress. If a highly efficacious person is denied control or coping 
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efforts continue in situations where control is not possible, then 
distress results. Individuals with low self—efficacy who are given 
control do not cope with stressful conditions. If low efficacious 
individuals are denied control over stressful events then distress may 
be minimised. These predictions are supported by empirical evidence 
(see Litt, 1988 for a review) and have implications for the interaction of 
self—efficacy with coping behaviour. 
Attribution styles differ from self—efficacy beliefs, in that the former 
pertain to the causes of events and not behavioural expectations. If, 
for example, illness is attributed to external, specific and unstable 
circumstances coping will be satisfactory and distress minimal. If, 
however, illness is attributed to internal, global and stable factors 
coping will be less effective and depression may arise (Litt, 1988). 
Self—esteem refers to individuals liking or respect for themselves, 
whereas self—efficacy pertains to performance capabilities (Litt, 1988). 
This distinction can be illustrated by an example. An individual can 
have high self—efficacy for completing a task but derive no increase in 
self—esteem from its successful accomplishment. Frequently, however, 
high self—efficacy and self—esteem occur together. That is, individuals 
develop high self—efficacy from activities that also promote 
self—esteem. 
The coping process involves primary and secondary appraisals 
(Larazus & Folkman, 1984). Primary appraisals involve judgments of 
whether an event is stressful and secondary appraisals concern 
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possible courses of action. Secondary appraisals are complex and 
involve decisions about possible coping strategies, the likelihood of 
their success (outcome expectation) and whether the individual can 
apply these strategies (self—efficacy). Efficacy expectations are part of 
the secondary appraisal process (Strecher et al., 1986). Efficacy beliefs 
also are mediators of the duration and effort of coping behaviour 
(Bandura, 1977, 1978, 1982). Highly efficacious individuals use a wider 
variety of strategies to cope with the temptation to smoke than persons 
with low self—efficacy beliefs (Garcia et al., 1990). High self—efficacy 
expectations also are associated with adaptive problem—focused coping 
and low expectations with the use of less effective means of reducing 
distress, such as emotion—focused coping (DiClemente, et al.,1985). 
The personal resources discussed above interact with self—efficacy 
beliefs to influence behaviour. For example, high self—esteem and 
self—efficacy beliefs usually co—occur. There are, however, clear 
distinctions between the reviewed personal resources and self—efficacy. 
These distinctions were emphasised to affirm that the present study is 
focusing on the specific concept of self—efficacy and not a wider 
definition adopted in some research. 
SELF—EFFICACY AND AUTOIMMUNE DISEASE RESEARCH 
Studies with chronically ill individuals usually adopt wide definitions 
• that only remotely resemble Bandura's notion of self—efficacy. The 
following review considers only studies that narrowly define 
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Bandura's notion of self-efficacy. These studies have used either RA 
or SLE sufferers. 
A study of 101 individuals with rheumatoid arthritis found high 
self-efficacy scores were related to less functional disability 
cross-sectionally and prospectively after one year (Schiaffino, 
Revenson & Gibofsky, 1991). Strong self-efficacy beliefs also were 
related to the use of adaptive problem-focused coping and lower 
disability levels one year after the initial assessment. Self-efficacy was 
not related to depression on either assessment occasion. Pain levels 
did, however, interact with self-efficacy beliefs for predicting 
depression after one year. When pain was minimal, self-efficacy was 
not associated with depression; high pain levels accompanied by 
strong self-efficacy beliefs were related to elevated depression levels. 
Whether this latter finding was further mediated by problem-focused 
coping skills was not considered. While the Schiaffino et al. study 
demonstrates a complex interaction between self-efficacy and health, it 
is flawed by the assessment strategies used. The self-efficacy measure 
was specifically related to disability and thus not appropriate for 
predicting depression, coping or pain levels. 
A complex relationship between self-efficacy and life satisfaction is 
also evident in the adjustment to rheumatoid arthritis (Smith, 
Dobbins SE Wallston, 1991). Using path analysis the study found an 
internal locus of control was associated with high self-efficacy and 
greater life satisfaction, whereas the unavailability of instrumental 
social support was associated with low self-efficacy and high 
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depression levels. High life satisfaction levels were predicted by high 
self-efficacy beliefs, an internal locus of control and satisfactory 
instrumental social support. 
An intervention study found that enhancing self-efficacy levels lead 
to changes in a range of cognitive and behavioural domains for 
rheumatoid arthritis sufferers (O'Leary, Shoor, Long & Holman, 1988). 
Enhancing self-efficacy beliefs decreased pain, disability, stress and 
depression levels and increased physical functioning. High 
self-efficacy levels also were associated with higher 
suppressor /cytotoxic T-cell numbers. Strengthening self-efficacy 
beliefs did not, however, enhance activity levels or improve 
immunological functioning. This latter finding may have been due to 
the confounding effects of medication on immune parameters. 
Another limitation was that conservative statistical approaches were 
not utilised in analyses- one-tailed significance tests were adopted and 
Bonferroni corrections for multiple comparisons were not considered. 
Thus it is difficult to conclude that increasing self-efficacy improves 
cognitive and behavioural functioning in individuals with 
rheumatoid arthritis. 
A descriptive study with 201 SLE sufferers reported increases in 
self-efficacy over time (Braden, 1991). Since there were no 
experimental manipulations and no comparison groups were 
included, Braden's data only provides test-retest reliability of 
self-efficacy measure. Furthermore, the self-efficacy assessment used 
a visual analogue scale in which respondents were asked "How 
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satisfied are you with your ability to control fatigue" (Braden, 1991, 
p.162, italic added). No evidence of the construct validity of this 
measure was provided. 
In summary, self—efficacy beliefs concern one's capability of 
performing specific behaviours. These beliefs arise from past 
behavioural accomplishments and the expected outcome of a 
situation. Empirical data suggest that self—efficacy mediates disease 
outcomes, such as depression, disability and pain, in individuals with 
autoimmune diseases. These studies have not, however, established 
whether self—efficacy levels differ between chronically ill and healthy 
people or whether self—efficacy is a significant predictor of disease 
outcome. 
2.2.2 COPING 
The most widely accepted model of coping behaviour involves three 
stages; stress appraisal, perceptions of control and coping behaviour. 
While this model is well researched in psychology, it is less often 
adopted by medical researchers. This section reviews the Lazarus and 
Folkman (1984) coping model and reviews studies investigating 
coping in autoimmune diseases. The review does not include studies 
with SLE sufferers, as the author was unable to locate any published 
studies. 
THEORY 
Lazarus and Folkman (1984) define coping as 
"...the person's constantly changing cognitive and behavioural 
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efforts to manage specific external and/or internal demands 
that are appraised as taxing or exceeding the person's 
resources." 
(p.141) 
This definition asserts that coping efforts are dynamic, have cognitive 
and behavioural properties and are a response to a taxing situation. 
The Lazarus and Folkman coping model proposes that distress results 
from how an individual appraises a stressful situation. The appraisal 
process has three stages. The first stage is primary appraisal and 
concerns judgments about whether an event is harmful. The next 
stage is termed secondary appraisal and is concerned with whether an 
individual perceives an event as controllable. In the third stage 
individuals employ emotional and behavioural strategies that 
alleviate stress. 
Lazarus and Folkman also distinguish between problem and 
emotion-focused coping. Problem-focused coping consists of 
strategies aimed at problem solving or doing something to alter the 
source of stress. Emotion-focused coping is aimed at reducing or 
managing the emotional distress associated with a stressful event. 
While most stressors elicit both problem and emotional focused 
coping responses, problem-focused coping predominates when 
individuals feel they can actively reduce stress and emotional focused 
coping dominates when individuals believe that the stressor can only 
be endured. Other dimensions of coping such as maladaptive coping 
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and social support as coping assistance also have been identified 
(Thoits, 1986; Carver, Scheier & Weintraub, 1989). 
The final assertion of the Lazarus and Folkman model is that coping is 
a dynamic process that reflects the contextual aspects of stress. While 
this notion has merit, coping also has dispositional qualities (Carver et 
al., 1989). That is, individuals have a preferred set of coping responses 
that they take into stressful situations. This study adopts a 
questionnaire measuring both the contextual and dispositional aspects 
of coping behaviour. 
COPING AND AUTOIMMUNE DISEASE RESEARCH 
Studies have focused on issues such as coping typologies, the use of 
downward comparisons as a coping strategy and the relationship of 
coping to depression, disability and pain. This section focuses on 
studies of individuals with rheumatoid arthritis, as there has been no 
research with SLE sufferers. Most of the cited research does not 
incorporate current theoretical notions of coping and is not theory 
driven. 
A study with 158 outpatient RA sufferers used cluster analysis to group 
individuals according to the coping strategies they most typically used 
(Newman, Fitzpatrick, Lamb & Shipley, 1990). The mostly widely 
used strategy was passive coping. Passive copers did not adhere to any 
particular strategies but used a wide range of responses to a moderate 
extent. Another group used both emotion and problem-focused 
strategies to cope with their RA and associated pain. The third group 
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were active in coping with their condition. They rarely used social 
support as coping assistance. The final group consisted of RA sufferers 
who utilised social support or religion to cope with their condition. 
These empirically derived groups were not distinguishable on 
demographic factors, psychopathology, social support or disease 
activity. Notable differences in disability scores were, however, 
apparent between the groups, with active coping group reporting 
lowest levels. While the results of this study are encouraging, the 
measure of coping was devised on an ad hoc basis from existing scales 
and its reliability was not established. 
Another study examined downward and upward comparisons as a 
coping mechanism in individuals with RA and mothers of acutely ill 
newborn babies (Affleck, Tennan, Pfeiffer, Fifield & Rowe, 1987). 
Downward comparisons involve viewing others as less fortunate than 
oneself and upward comparisons concern viewing others more 
favourably than oneself. The notion that downward comparisons are 
common in RA and mothers was supported. Only rarely were upward 
comparisons made. The majority of respondents, however, did not 
use either downward or upward comparisons as a coping strategy. The 
descriptive nature of this study and the fact that raters were not blind 
to the hypotheses make the results unreliable. 
The Coping Strategies Questionnaire (CSQ) conceptualises coping as 
either cognitive or behavioural (Beckham, Keefe, Caldwell & 
Roodman, 1991). Using this questionnaire Beckham and associates 
found that RA sufferers using pain control and rational thinking as 
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coping strategies reported less depression, disability, hassles and pain 
than individuals not using such strategies. This relationship was 
independent of demographic factors including age and gender and 
medical variables such as disease severity. Since this study used a 
correlational design, the direction of the coping and adjustment 
relationship cannot be inferred. Furthermore, the cognitive coping 
dimension of the CSQ confounds personal resources, such as 
self-efficacy and self-esteem, with the process of coping. 
The relationship between coping strategies, pain and depression was 
investigated by Brown and associates (Brown, Nicassio & Wallston, 
1989). The subjects were 287 R A sufferers who had been diagnosed for 
seven years or less. Two dimensions of coping were examined, passive 
(or emotion-focused coping) and active coping (or problem-focused 
coping). Cross-sectionally and over a six month period, an interaction 
between passive coping, pain and depression was present. Individuals 
who were passive copers with high pain levels were more depressed 
than people not using such coping strategies. Individuals who were 
active copers reported low depression and pain levels when compared 
with passive copers. Since a correlational design was utilised, causality 
problems also exist with this study. While passive coping in the 
presence of pain may lead to high depression levels, depression may 
lead to poor coping and elevated pain levels. There also was a 
problem with the coping measure use in the Brown et al. study. The 
range of scores for passive coping was greater than for active coping, 
potentially biasing the assessment of the former coping dimension. 
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Furthermore, without the inclusion of a depressed pain comparison 
group, few conclusions about result specificity are possible. 
A longitudinal study with 45 RA sufferers used the Ways of Coping 
Questionnaire (Lazarus & Folkman, 1984), to assess its relationship 
with self-efficacy, disability and affect (Revenson & Felton, 1989). 
More individuals relied on emotion-focused coping than on 
problem-focused strategies. While coping was not associated with 
either disability, self-efficacy or negative affect, it was associated with 
positive affect. Individuals using problem-focused strategies were 
more likely to report positive than negative affective states. Like the 
aforementioned studies, the correlational design lead to cause and 
effect problems. Also the effects of time-1 affect, disability and 
self-efficacy were not partialled out when predicting time-2 coping, 
thus confounding existing adjustment with subsequent coping 
strategies. 
While this review is not comprehensive, it highlights the limitations 
of studies of coping in chronic illness sufferers. Most studies use 
questionnaires without established psychometric properties, instead 
choosing to derive coping measures ad hoc. Furthermore, few 
investigations assess whether there are characteristic differences in 
coping responses between different types of illnesses and whether ill 
individuals cope differently from healthy controls. 
In sum, the Lazarus and Folkman coping model is widely cited in 
psychological research but rarely is incorporated in studies with 
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chronically ill people. The model proposes that coping occurs as a 
three stage process and distinguishes between emotional— (passive) 
and problem—focused (active) coping strategies. Although coping is 
hypothesised as situation specific, it also has dispositional elements. 
How individuals with SLE cope compared with other chronically ill 
and healthy people has not been reported nor has the interaction of 
coping with disease outcome measures. 
2.3.0 DISEASE OUTCOME MEASURES 
These measure the consequences of chronic illness and include 
psychological distress (or psychopathology), physical disability, 
psychosocial disruption (e.g., communication limitations) and life 
style disruption (e.g., eating difficulties and recreational restrictions). 
However, only one SLE disease outcome measure, psychopathology, 
has received substantial research. The effects of SLE on the other 
outcome measures has not been reported. 
2.3.1 PSYCHOLOGICAL DISTRESS 
High psychopathology (or psychological distress) rates have been well 
documented in SLE sufferers and can be arbitrarily classified as either 
organic or adjustment syndromes. Organic or neurological syndromes 
arise from the pathogensis of SLE and include seizures and cognitive 
decline. Adjustment reactions emanate from problems associated 
with living with SLE. For example, the unpredictable disease course 
may result in depression, fatigue may lower sufferers resistances to 
stress and weight gains associated with using corticosteriods may lower 
self—esteem. 
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INCIDENCE AND SYNDROMES 
A study by Rimon, Kronqvist and Helve (1988) found a 
psychopathology rate of 19 percent. The most common syndrome was 
depression in 13 percent of SLE patients. Depressive symptoms ranged 
from mild to severe cases, with neurotic depression most frequently 
diagnosed. Organic brain syndromes were present in 10 percent of 
individuals. The psychiatric status of 83 percent of the original sample 
was followed longitudinally for three years. Over this period, 36 
percent of individuals with SLE experienced depressive illness and 16 
percent organic brain syndromes. These syndromes persisted during 
the entire follow-up period. Although the Rimon and associates' 
study is prospective, psychiatrists were not 'blind' to patients' previous 
psychiatric histories and a comparison group was not included. 
An investigation of psychopathology rates prior to and after the onset 
of SLE as well as cross-sectionally during an interview shows the latter 
approach yields the highest estimates (Lim, Ron, Ormerod, David, 
Miller, Logsdail, Walport & Harding, 1988). The sample consisted of 40 
sufferers (36 outpatients and 4 inpatients) and a comparison group of 
14 R A sufferers and 13 inflammatory bowel patients. Six SLE and no 
control patients reported signs of psychopathology before the onset of 
their condition. Using DSM-III criteria, three SLE patients experienced 
anxiety conditions, two major depressive disorder and one an organic 
brain syndrome. Twenty-five SLE patients and eight controls reported 
psychopathology after the onset of their condition. For individuals 
with SLE, major depression was present in 16 instances, anxiety in four 
cases and atypical psychoses in five individuals. At a cross-sectional 
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interview 40 percent of SLE and 30 percent of controls were identified 
as 'psychiatric cases'. From the interview, two SLE patients had 
psychotic symptoms, eight had major depression and six anxiety 
disorders. Concurrent measures indicated that psychopathology was 
associated with high stress levels, but not with objective indices of 
disease activity. Furthermore, psychopathology was not associated 
with the presence of neurological changes. 
Psychiatric interviews and psychometric tests were used to quantify 
psychopathology rates in 30 outpatients and 49 inpatients with a 
diagnosis of SLE (Kremer, Rynes, Bartholomew, Rodichok, Pe1ton, 
Block, Tassinari & Silver, 1981). Forty—six percent of the sample were 
judged to have some current psychopathology, though the degree of 
disturbance was only mild. A sample of 37 individuals completed the 
MMPI, of this group 61 percent were classified as showing 
psychopathology. Scores were elevated on the hypochondriasis, 
depression and hysteria scales, a profile that is usually associated with 
neurotic concerns. These findings were unrelated to disease severity, 
neurological involvement or corticosteroid dosages. The efficacy of 
psychiatric interviews and psychological testing cannot, however, be 
evaluated as only a subsample completed the MMPI. 
Elevated depression, hypochondriasis and hysteria scores on the MMPI 
also were found by Liang and associates (Liang et al., 1984). This profile 
pattern was unrelated to disease duration, stressful life event scores or 
whether individuals were diagnosed with SLE or RA. For individuals 
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with SLE, however, depression was correlated with high social 
disruption scores on the life events inventory. 
Standardised psychological tests also were employed by Allen and 
Glicksman (1986) to assess psychopathology in SLE patients. This study 
found similar Profile of Mood States (POMS; McNair, Lorr & 
Doppleman, 1971) between individuals with SLE and the norms for 
healthy subjects. These groups in turn were significantly different 
from psychiatric patients who had elevated POMS profiles. One 
explanation for the contrary findings of the Allen and Glicksman 
study is they used a community sample of individuals with SLE while 
other studies use outpatient or hospitalised sufferers. A more likely 
explanation, however, concerns design flaws with the study. Only 22 
percent of individuals approached volunteered for the study and no 
attempt was made to confirm these people met the ARA criteria for 
SLE. The POMS also is not considered a measure of psychopathology 
but rather an assessment of affect (McNair et al., 1971). There also were 
no appropriate control groups, rather SLE sufferers were compared 
with POMS norms. 
In sum, the psychopathology rate for SLE sufferers varies between 19 
and 71 percent. This large discrepancy arises from measurement 
strategies and the classification of psychological states. 
ETIOLOGY 
The preceding review suggested that for about 10 percent of sufferers 
psychopathology has an organic etiology and in five percent of SLE 
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patients it arises from the side—effects of medication. Over 85 percent 
of psychopathology is reactive and arises from factors that are not well 
understood. 
ORGANIC 
Psychopathology can result from disease complications such as 
hypertension and renal dysfunction. When this occurs, the 
administration of corticosteroids reduces disease severity and 
symptoms of psychopathology (Adelman, Saltiel & Klinenberg, 1986). 
Changes in cerebral blood flow occasionally cause psychotic symptoms 
in sufferers (Adelman, et al., 1986). Immune deposits in the choroid 
plexus of the brain also are implicated in the etiology of psychotic 
episodes. Similar deposits are reported in the brains of individuals 
with schizophrenia, leading to the notion that SLE may provide a 
model for schizophrenia. Autopsy studies report enlarged brain sulci 
in individuals with a history of psychiatric symptoms, but these 
observations are based on small samples and are not consistently 
replicated (Adelman, et al., 1986). Fatigue also is a common symptom 
of SLE and can lower depression and anxiety thresholds. 
Corticosteroid medications cause signs and symptoms of psychosis in 
approximately five percent of individuals with SLE. Individuals with 
preexisting psychopathology or organic brain diseases are at greater risk 
for steroid induced psychosis than are people without such a history 
( Wallace & Dubois, 1987). The notion of a steroid induced psychosis is 
however controversial. Some evidence suggests that psychotic 
symptoms can improve following administration of corticosteroids. 
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Furthermore, withdrawal of steroid does not always lead to the 
symptoms of psychosis abating. 
ADJUSTMENT REACTIONS 
The majority of psychological syndromes are reactive and probably 
result from changes in social functioning or the erosion of personal 
resources. Limited research has documented that elevated stress levels 
precede psychological distress and that self—efficacy training lowers 
distress. Research with other autoimmune diseases suggests that 
decreases in social support and emotion—focused coping strategies also 
elevate psychological distress levels. Clearly further research on 
variables moderating psychological distress is required. 
2.3.2 FUNCTIONAL DISRUPTION MEASURES 
Figure 1 provides a summary of the different approaches for assessing 
health outcomes. Levels 1-4 are objective measures and are used 
mainly in epidemiology studies to assess disease outcomes. Level one 
assessments quantify self—reported symptoms of disease such as 
headaches or somatic complaints. Level two measures the incidence 
or prevalence of disease as an outcome. The third level is an indirect 
disease outcome measure and is based on parameters such as 
prescriptions or surgical procedures. Level five, estimates health 
outcomes from mortality rates. 
A different approach estimates functional disruption arising from 
illness (level four). In this approach performance is classified as (1) 
physical such as changes in ambulation, mobility and body movement 
Psychological factors 
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Signs and Symptoms 
.l evel One) 
Self-perceptions of illness 
Medical diagnosis of disease 
• Level Two 
ical treatrnent of disease 
Level Three 
Mortality 
Level Five 
Functional ci isahili ty  , 
Psychological distress 
Psychosocial disruption 
Level Foul 
Figure 1: Medical approaches for assessing health outcomes 
(Modified from Bergner, 1988, page 82) 
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(2) psychosocial which includes disturbances in emotional behaviour, 
communication and alertness behaviour and (3) life style covering 
impairments in sleep, recreation, work and home management. The 
correlation magnitude between objective (levels 1-3) and functional 
approaches is typically moderate suggesting they measure distinctive 
aspects of disease outcome. In behavioural research, however, 
functional disruption measures have several advantages over the 
objective approach. A range of medical complaints can be compared 
irrespective of symptomatology or treatment. They also are sensitive 
to improvements in patient activity levels and are easily administered 
as self-report measures. 
Only one study has measured the relationship between physical 
disability, psychosocial impairment and stress in SLE sufferers 
( Wekking et al., 1991). For individuals with SLE, but not the RA 
group, high stress levels were associated with elevated physical 
disability scores (i.e., mobility, physical ability, dexterity) and greater 
psychosocial disruption (i.e., anxiety, depression and social interaction) 
as assessed by The Arthritis Impact Measurement Scales (Meenan, 
Gertman & Mason, 1980). Disease outcome measures also were 
significantly correlated with objective indices such as auto anti-body 
levels and erythrocyte sedimentation rate (an index of inflammation 
and hence disease activity). Unfortunately, the study used a small 
sample size (n=13) so the findings should be viewed with caution. 
2.4.0 CHAPTER SUMMARY 
Consistent with earlier studies, disease outcomes are postulated to be 
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influenced by social and personal resources. Social resources are those 
variables influenced by external events and include stress, social 
networks and social support. Personal resources are mediated by 
perceptions rather than external events and include self—efficacy and 
coping strategies. The outcome of chronic illness includes indices such 
as psychological distress, physical disability or psychosocial disruption. 
The social resources reviewed in this chapter were stress, social 
networks and support. Stress levels were similar in SLE and RA 
sufferers but higher than for 'healthy' controls ( Wekking et al., 1991; 
Otto & Mackay, 1967; respectively). Furthermore, stress was related to 
disease outcomes for SLE sufferers, but not for people with RA 
( Wekking et al., 1991). Correlation research adds an additional 
dimension to the comparative studies. One study found that stress 
arising from a loss of social support exacerbated disease activity for SLE 
sufferers (Laing et al., 1984). The aforementioned conclusions are 
however based on a synopsis of findings from studies using different 
respondents and methodologies. A more advantageous approach 
would be to incorporate comparative and correlational designs to 
investigate stress levels and disease outcomes in the same group of 
subjects. 
Comparative studies of social network size and support levels for SLE 
sufferers are lacking. One correlational study reported that the loss of 
social support in the presence of high stress exacerbated disease activity 
(Laing et al., 1984). But the study did not test the buffering model of 
social support. Correlational studies with other chronic conditions, 
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• however, generally do not find a main—effect for social networks 
(Brown et al., 1989), but show a buffering effect for social support 
(Brown, et al., 1989; Fitzpatrick et al., 1991; Revenson et al., 1991). Since 
the affects of social relationships on disease outcome are not widely 
reported for SLE sufferers, it would be advantageous to adopt both 
comparative and correlational procedures to investigate these 
hypotheses. 
The personal resources reviewed in this chapter included self—efficacy 
and coping. Comparative studies of self—efficacy have not been widely 
reported for SLE or other chronic illness sufferers. Several 
correlational studies have found that high self—efficacy perceptions are 
associated with a large social network, more social support and the use 
of problem—focused coping strategies (Wiedenfeld et al., 1990; 
Schiaffino, 1991; Smith et al., 1991). Again, comparative and 
correlational studies reporting the interaction of self—efficacy with 
other social and personal resources, as well as how it relates to disease 
outcomes are required. 
Chronically ill people use more emotion—focused coping than 
problem—focused strategies. Whether they differ from 'healthy' 
controls has not however been reported. In correlational studies, 
illness sufferers using more problem—focused coping strategies report 
less disability and distress than those people who rely on 
emotion—focused strategies. Furthermore, problem—focused copers 
report fewer hassles and higher self—efficacy than people using 
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emotion—focused strategies (DiClemente, et al., 1985; Schiaffino, 1991; 
Smith et al., 1991). 
The disease outcomes reviewed in this chapter were psychological 
distress, physical disability and psychosocial disruption. How social 
and personal resources influence disease outcomes for SLE is not well 
documented. For example, the incidence of psychopathology is widely 
reported and is believed to stem from adjustment problems associated 
with SLE. Nonetheless, how social and personal factors contribute to 
psychological distress in SLE sufferers is not well documented. Using 
physical disability as a disease outcome measure, one study found a 
correlation with elevated stress levels in SLE sufferers ( Wekking et al., 
1991). Thus there also is a need for comparative studies to establish 
where differences result on outcome measures and correlational 
research to determine which social and psychological resources may 
influence outcomes. 
Throughout the chapter emphasis was placed on the need for 
comparative and correlation studies. The present study, therefore, 
includes another illness comparison group and healthy controls. 
Multiple sclerosis (MS) was chosen as the other illness comparison 
group for several reasons. It also is an autoimmune disease that 
occurs more often in females than males and has its onset during the 
child bearing years. The disease course of MS is characterised by flare 
and remission periods and exacerbations are usually managed with 
corticosteroids. Sufferers also are likely to experience their symptoms 
several years before a diagnosis is reached. The important difference 
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from SLE, is that antibody attacks are specific to the myelin sheath 
encasing central nervous system neurons. This difference in 
symptomatology, rather than the demographic characteristics of the 
diseases, will explain any observed disparities between the illness 
groups. The inclusion of a healthy control group allows conclusions 
about whether group differences are specific to chronic illness. The 
three group comparative design makes a useful contribution to 
research as it identifies and quantifies which social and personal 
resources are adversely affected by having SLE. The design also allows 
conclusions about whether changes are specific to SLE or occur in 
other chronically ill people. 
The study design also allows for correlational and regression analyses 
to examine the relationship between variables cross-sectionally. 
While these analyses will generate hypotheses for further research, 
without longitudinal data firm conclusions about directionality and 
causality are not possible. For example, decrements in the availability 
of social and personal resources may result from, or contribute to, 
disease exacerbation. 
To conclude, the literature suggests a Disease Exacerbation Model for 
the course of the disease and and its impact on social and personal 
resources. This model predicts that the course of the chronic diseases 
will lead not only to a deterioration in the disease outcome measures, 
but also to a deterioration in various measures of social and personal 
resources. It is also to be expected that there will be some underlying 
casual relationships in which a diminution of certain social and 
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personal resources wil impact upon the disease process further 
exacerbating the outcome as indicated by the distress, disability and 
disruption measures. 
2.5.0 HYPOTHESES 
GROUP DIFFERENCES 
Folowing from the literature review, there is insufficient evidence to 
predict differences between the SLE and MS groups on any social, 
personal or disease outcome variable, except that the MS group may be 
expected to report greater physical disability. In accordance with the 
Disease Exacerbation Model, healthy controls may be expected to difer 
from chronic ilness sufferers on al the social, personal and disease 
outcome measures. Expected diferences between healthy controls and 
the chronic ilness groups are as folows: 
a. 	 The ilness groups wil report more hassles and fewer uplifts 
than healthy controls. 
The social network size of healthy controls wil be larger when 
compared with SLE and MS suferers. 
c. SLE and MS suferers wil report less social support when 
compared with healthy controls. 
d. Self-eficacy levels wil be higher for healthy controls than the 
chronic ilness groups. 
e. Controls wil report more problem-focused coping than either 
SLE or MS suferers. 
f. The chronic ilness groups wil report more emotion-focused 
coping than healthy controls. 
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g. The chronic illness groups will report more psychological 
distress than healthy controls. 
h. The chronic illness groups will report more physical disability 
than healthy controls. 
i. The chronic illness groups will experience more psychosocial 
disruption than healthy controls. 
To assist in interpreting group differences, correlational analyses also 
will be performed to identify relationships between personal, social 
and outcomes measures. Stepwise regression will be used to 
investigate the relative importance and strength of social and personal 
resources in predicting disease outcomes. 
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Chapter Three 
Method 
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3.1.0 DESIGN 
The design of this study involved the comparison of three matched 
groups: SLE, MS and healthy controls. The groups were matched for 
age, gender, marital and socioeconomic status. The dependent 
variables used in the study were measures of social resources, 
personal resources and disease outcomes. Social resource measures 
included hassles, uplifts, social networks and social support. Personal 
resource measures were self—efficacy, problem— and emotion-focused 
coping. Disease outcome measures were physical disability, 
psychological distress and psychosocial disruption. A description of 
the various measures and the psychometric properties is provided in 
section 3.3.0. 
The hypotheses were subsequently evaluated by analysis of variance 
to assess differences in group means on the various dependent 
variables. Correlation and regression analyses were also performed 
to assess relationships between the social, personal and disease 
outcome measures. For further details of the statistical procedures 
see page 83. 
3.2.0 PARTICIPANTS 
The groups of participants were recruited in different ways. A 
representative from the Tasmanian Lupus Society contacted 
members to explain the study. Of the 50 members, 34 volunteered to 
participate. This represents a response rate of 68 percent. The 34 
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volunteers met three or more ARA criteria and were diagnosed with 
SLE by either a specialist rheumatologist or general practitioner. 
For individuals with MS, a written explanation of the study was 
forwarded by the Tasmanian Multiple Sclerosis Society only to 
members with a diagnosis confirmed by a neurologist. This was 
accompanied by a postcard asking about demographic information 
and a reply paid envelope. Of the 280 members sent information 
about the study, 141 volunteered to participate. This represents a 
response rate of about 50 percent. Since it was not possible to 
interview all the volunteers, a random sample of 40 individuals with 
MS were selected. Complete data sets were obtained from 37 
individuals with MS, three were eliminated from analyses due to 
missing data. 
The control group was selected from various community facilities 
including clubs and social organisations. Complete data sets were 
obtained from 38 controls, after three were eliminated with missing 
data. 
Controls were selected so that the distribution of age, gender and 
socioeconomic status (SES) was approximately equal to the SLE and 
MS groups (Table 2). None of the groups differed on the 
demographic measures [age, F(2,105)=1.56, p=.21; SES, F(2,106)=1.21, 
71 
p=.30; gender, X2=1.64, df=2, p=.44; marital status 3, X2=2.12, df=2, 
p=.351. 
Table 2: Demographic characteristics of participants. 
GENDER 
SLE MS CONTROLS 
males 6 7 11 
females 28 30 27 
AGE (years) 
mean 49.05 44.19 44.78 
SD 16.24 8.19 12.14 
MARITAL STATUS 
single 2 6 9 
married/defacto/widowed 29 28 27 
separated/divorced 3 3 2 
DANIELS SCORE (OCCUPATIONAL SES; Daniels, 1983) 
mean 31.94 30.24 29.28 
SD 7.48 4.97 8.82 
All participants gave written informed consent to take part in the 
study. A copy of the consent form appears in appendix one. 
3.3.0 QUESTIONNAIRES 
Only questionnaires derived from established psychological theories 
and with robust psychometric properties were used in the study. 
Copies of these questionnaires appear in appendix one. Since the 
'The categories of single and separated/divorced were combined. 
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Sickness Impact Profile and the SCL-90—R have restricted availability, 
they do not appear in the appendix. 
DEMOGRAPHIC AND DISEASE HISTORY QUESTIONNAIRE 
The demographic questionnaire asks respondents about their age, sex 
and socioeconomic status as measured by the Daniels Score (Daniels, 
1983). For individuals with SLE or MS, information about disease 
duration, medication and disease status was also collected. 
SOCIAL RESOURCES 
The social resources measures used in the present study (short—hand • 
variable names in brackets) were daily hassles [HASSLES], uplifts. 
[UPLIFTS], social network [NETWORK] and social support 
[SUPPORT]. 
DAILY HASSLES AND UPLIFTS SCALES [HASSLES & UPLIFTS] 
Fifty—three items are rated for the amount of stress (hassles) and 
pleasure (uplifts) they have provided in the past 14 days (Delongis, 
Folkman & Lazarus, 1988). Although separate scales have been 
devised to measure hassles and uplifts, it is recognised that a given 
event may have both qualities. Recent research suggests hassles and 
uplifts contribute differentially to disease outcomes, so there are 
included as separate dependent variables in the present study 
(Chamberlain & Zika, 1990). 
73 
NORBECK SOCIAL SUPPORT QUESTIONNAIRE [NETWORK] 
The Norbeck Social Support Questionnaire was constructed to 
measure network size, functional support and social losses. In the 
present study, only the network size subscale is used since more 
robust social support measures are available. To complete the 
network measure, respondents list persons who are potential sources 
of support and specify the nominated person's relationship (e.g., 
family, coworker or practitioner). The network subscale has a 
test—retest reliability of .92 (Norbeck, Lindsay, & Carrieri, 1981). 
INTERPERSONAL SUPPORT EVALUATION LIST [SUPPORT] 
The Interpersonal Support Evaluation List (ISEL) comprises 40 
statements concerning the availability of emotional, tangible, 
belonging and appraisal social support. The tangible subscale 
measures the availability of material aid; the appraisal subscale 
assesses the availability of someone with whom to discuss problems; 
the self—esteem subscale measures the availability of a positive 
comparison when comparing one's self with others; and the 
belonging subscale assesses the availability of people with whom one 
can do things. The true/false format of the ISEL is counterbalanced, 
with half the items inquiring about positive aspects of social support 
and the other half about negative aspects. Scores on the four ISEL 
subscales are summed to yield an estimate of total social support. 
Test—retest reliabilities range between .63 and .70 for the individual 
subscales and internal consistencies from .88 to .99. The ISEL has 
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documented discriminant and convergent validity (see Cohen, 
Mermelstein, Kamarck & Hoberman, 1985). 
PERSONAL RESOURCES 
The personal resource measures adopted in the present study 
(short-hand variable names in brackets) were self-efficacy 
[EFFICACY], emotion-focused coping [EMOTION] and 
problem-focused coping [PROBLEM]. 
SELF-EFFICACY [EFFICACY] 
The 22-item Coppel (1980) scale has documented psychometric data 
including internal validity (.91), test-retest reliability (.86), 
convergent validity and factor structure. It measures behaviours 
related to self-efficacy including behavioural maintenance and 
outcome expectancies. It is a disposition measure and, therefore, 
equally applicable to SLE, MS and healthy people. Self-efficacy levels 
are reported as a single total score. 
COPE [EMOTION & PROBLEM] 
The COPE consists of 53 items that were derived from Lazarus and 
Folkman's (1984) notion of emotional- and problem-focused coping 
(Carver, et a., 1989). It consists of 13 subscales, 10 of which represent 
three broad coping domains. These domains are active (or 
problem-focused), supportive and maladaptive (emotion-focused) 
coping and are not summed to yield a total COPE score. The 
remaining three scales measure coping responses that are neither 
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adaptive nor maladaptive and are not included in the domain totals 
or the present study. Individual COPE subscales have an internal 
consistency ranging from .62 to .92, a two week test-retest reliability 
of .61, as well as documented discriminant and convergent validity 
(Caver et al., 1989). 
Since the COPE assesses both the situational and dispositional aspects 
of coping behaviour and is derived from the Folkman and Lazarus 
model, it was chosen for the present study. To be consistent with the 
Folkman and Lazarus model, only scores on the the emotion- and 
problem-focused domains were used in the analysis. The subscales 
that comprise problem-focused and emotion-focused coping domain 
scores appear in Table 3. 
DISEASE OUTCOMES 
Outcome measures are the consequences of illness and include 
(short-hand variable names in brackets) psychological distress 
[DISTRESS], physical disability [PHYSICAL] and psychosocial 
impairment [DISRUPTION]. 
PSYCHOLOGICAL DISTRESS [DISTRESS] 
The revised 90 item Symptom Check-List (SCL-90-R) is a self-report 
measure of current psychological distress, consisting of 90 items, each 
rated on a five-point scale (Derogatis, 1983). The scale yields nine 
primary symptom dimensions and three global scores of distress 
(Table 4). The general symptom index (GSI) is considered the most 
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informative psychopathology measure and is adopted in the present 
study (Brophy, Norvell & Kiluk, 1988). The SCL-90-R has a flexible 
timeframe and in the present study psychological distress over the 
past 14 days is assessed. The psychometric properties of the SCL-90-R 
are robust and have been reviewed by Brophy and associates (Brophy 
et al., 1988). A standardised SCL-90-R score of 63 is used to diagnose 
clinical syndromes (Derogatis, 1977). The present study is concerned 
with general (rather than clinical) distress levels and adopts the GSI 
index rather than the cut-off criteria. 
SICKNESS IMPACT PROFILE [PHYSICAL & DISRUPTION] 
The SIP is a self-report measure of disability and psychosocial 
disruption associated with medical conditions. Respondents are 
asked to endorse only those items which describe their health over 
the past 14 days (Bergner, 1977). Items are weighted according to the 
severity of limitation on behaviour implied by each statement. The 
items cover a range of domains including sleep and rest, eating, 
work, home management, recreation and pastimes, ambulation, 
mobility, emotional behaviour, body care and movement, social 
interaction and communication. These subscales are summed to 
yield a measure of psychosocial and physical disability, as well as an 
overall sickness impact score. 
The psychometric properties of the SIP are reviewed by Wilkin and 
associates (Wilkin, Hallam & Doggett, 1992) and include high 
internal consistency, test-retest reliability and inter-rater reliability. 
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Table 3: The problem—focused and emotion—focused COPE subscales. 
(After Carver et al., 1989) 
PROBLEM-FOCUSED COPING 
ACTIVE COPING 
Taking action, exerting efforts, to remove or circumvent the stressor. 
PLANNING 
Thinking about how to confront the stressor, planning one's active coping efforts. 
SUPPRESSION OF COMPETING ACTIVITIES 
Suppressing one's attention to other activities in order to concentrate on coping with the 
stressor. 
POSITIVE REINTERPRETATION 
Making the best of a situation by viewing it in a more favourable light. 
RESTRAINT 
Holding back one's coping efforts until they are effective. 
EMOTION-FOCUSED COPING 
ACCEPTANCE 
Accepting that the stressful event has occurred. 
FOCUS ON & VENTING EMOTIONS 
Increased awareness of emotional stress and a tendency to vent emotional distress. 
DENIAL 
Attempts to reject the reality of a stressful event. 
MENTAL DISENGAGEMENT 
Psychological disengagement from the goal with which the stressor is interfering, 
through daydreaming, sleep, or self-distraction. 
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Table 4: The SCL-90—R symptom dimensions 
and global distress indices. 
SOMATIZATION 
This dimension measures distress arising from bodily dysfunction. 
OBSESSIVE—COMPULSIVE 
Measures thoughts, impulses and actions that are experienced as unremitting and 
irresistible. 
INTERPERSONAL SENSITIVITY 
Focuses on feelings of personal inadequacy and inferiority. 
DEPRESSION 
Measures symptoms indicative of depression including dysphoric mood, withdrawal, loss 
of interest in usual activities and decreased energy levels. 
ANXIETY 
Assesses clinical signs of anxiety including nervousness, tension, panic attacks, feelings of 
terror and trembling. 
HOSTILITY 
Measures thoughts, feelings or actions that characterise the state of anger. 
PHOBIC ANXIETY 
This is a specific fear response to a person, place, object or situation which is 
characterised by irrational, avoidance or escape behaviour. 
PARANOID IDEATION 
Measures paranoid behaviours including protective thought, hostility, suspiciousness, 
grandiosity, centrality and delusions. 
PSYCHOTICISM 
This dimension measures behaviour indicative of schizophrenia and schizoid 
personality disorder. It assesses withdrawal, isolation, hallucinations and thought 
broad—casting. 
GLOBAL INDICES OF DISTRESS 
1. Global Severity Index (GSI) 
This score is considered the best single index of global distress, it combines information cri 
the number of symptoms and intensity of perceived distress. 
2. Positive Symptom Distress Index (PSDI) 
The PSDI is a measure of distress intensity corrected for the number of symptoms 
reported. 
3. Positive Symptom Total (PST) 
This assesses the number of symptoms reported independent of their severity. 
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The SIP also demonstrates high correlations with physician rated 
disability. It has been used in over 40 studies of patients suffering 
from various illnesses including chronic pain, arthritis, cancer, 
angina, heart failure, fatigue and lung diseases (Wilkinet al., 1992). 
Since the SIP assesses disability and psychosocial disruption resulting 
from illness, it is easily administered to both SLE and MS sufferers, as 
well as healthy controls. The present study uses physical disability 
and psychosocial disruption scores as distinct disease outcome 
measures. Examples of items comprising the physical SIP subscales 
appear in Table 5. 
3.4.0 PROCEDURE 
Data were gathered by conducting personal interviews so as to 
establish rapport and to insure completion of the questionnaires. 
Since SLE and MS are uncommon medical conditions, it was 
necessary to travel throughout Tasmania to interview the 
volunteers. Interviews were conducted at sufferers' residences and at 
a convenient time convient to the volunteer. For 95 percent of 
individuals, two short interviews were arranged each lasting about 
30-40 minutes. In the first interview rapport was established and 
several questionnaires completed. An explanation of the remaining 
questionnaires was then provided and individuals completed these 
over a 10-14 day period. During the second interview, questionnaires 
were scanned for their completeness and any questions volunteers 
raised answered. 
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Table 5: Examples of items comprising the physical disability and 
psychosocial disruption subscales. 
PHYSICAL DISABILITY 
BODY CARE & MOVEMENT 
I stand for only short periods of time. 
I do not maintain balance. 
I am in a restricted position all the time. 
I stay lying down most of the time. 
MOBILITY 
I am getting around only within one building. 
I stay home most of the time. 
I stay away from home for only brief periods of time. 
I am staying in bed more. 
PSYCHOSOCIAL DISRUPTION 
COMMUNICATION 
I am having trouble writing or typing 
I am understood with difficulty 
I do not speak clearly when I am under stress 
EMOTIONAL BEHAVIOUR 
I act nervous or restless 
I talk about the future in a hopeless way 
I get sudden frights 
One SLE and 10 MS sufferers reported visual problems or motor 
difficulties. For these individuals several short visits were arranged 
over a two week period where questions were read and answers 
scribed. 
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Controls were screened for the presence of a chronic illness or 
chronic symptomatology. Individuals in the healthy comparison 
group received a financial reward for completing the questionnaires. 
Questionnaires were scored according to their devised criteria and the 
data analysed using SPSS (version 4) and Statview III. 
( 
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Chapter Four 
Results 
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The design consisted of three groups matched for age and socioeconomic 
status. To control for Type I errors, group differences were first assessed 
by performing a one—way multivariate analysis of variance (MANOVA) 
on each group of dependent variables (social, personal and disease 
outcome measures). To elucidate differences found to be significant by 
MANOVA, one—way analyses of variance (ANOVA) and posthoc LSD 
tests were preformed on each dependent variable to test differences 
between pairs of means. The LSD tests were interpreted as significant 
only if the preceding ANOVA was significant. Correlation matrices for 
the separate groups were also determined. The significant correlations 
are considered only briefly, as the purpose of the matrices is to explain 
the possible processes underlying group differences. 
Stepwise multiple regression was used to determine which social and 
personal resource variables predicted disease outcomes and to establish 
the strength of any relationships. These analyses were performed 
separately for each group. An alpha level of .05 was adopted for all 
statistical tests. 
4.1.0 GROUP COMPARISONS 
Table 6 contains means and standard deviations for the social, personal 
and disease outcome measures. For the social measures the one-way 
MANOVA was statistically significant [Wilks Lambda=.81, F 
(8, 206)= 2.85, p=.0051]. Group differences were present for the uplifts 
[F (2, 106)= 5.43, p=.00571 and social support [F (2, 106)= 4.54, p=.0127] 
scales. Differences were attributable to SLE sufferers reporting fewer 
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uplifts than healthy controls or MS sufferers and the chronic illness 
groups scoring lower on the social support scale (Table 7). No group 
differences were evident on the hassles or network scales. 
For personal resource measures, the one—way MANOVA was also 
statistically significant [Wilks Lambda=.80, F(6, 208)= 3.94, p=.0009]. 
Group differences for the self—efficacy scale [F (2, 106)= 3.68, p=.0283] were 
due to healthy controls scoring higher than either the SLE or MS groups 
(Table 7). Differences on the emotion—focused coping scale 
[F (2, 106)= 5.89, p=.0037] were due to controls using fewer of these 
strategies than the SLE and MS groups (Table 7). There were no 
significant group differences on the problem—focused coping scale. 
Expected differences on the disease outcome measures were also present 
[Wilks Lambda=.55, F (6, 208). 12.22, p=.0001]. All groups differed 
statistically on the physical disability scale [F (2, 106). 24.81, p=.0001] with 
the MS group reporting the highest and controls the lowest rates (Table 
7). Significant differences on the psychosocial disruption measure 
[F (2, 106). 17.69, p=.0001] arose from the SLE and MS groups scoring 
higher than healthy controls (Table 7). Finally, differences on the 
psychological distress measures [F (2, 106)= 21.13, p=.0001] arose from 
controls reporting lower levels than the chronic illness groups (Table 7). 
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Table 6: Mean and standard deviation scores for social, personal and 
disease outcome measures. 
SCALES 
SOCIAL RESOURCES 
SLE 
(n=34) 
MS 
(n=37) 
CONTROLS 
(n=38) 
HASSLES 
mean 25.02 26.89 32.28 
SD 19.93 17.64 24.40 
UPLIFTS 
mean 35.52 43.13 53.89 
SD 22.13 20.27 28.06 
NETWORK 
mean 14.44 12.59 13.07 
SD 6.77 8.31 5.94 
SUPPORT 
mean 29.02 29.78 33.86 
SD 8.58 8.62 4.36 
PERSONAL RESOURCES 
EFFICACY 
mean 62.17 62.05 68.21 
SD 11.18 12.97 9.06 
PROBLEM* 
mean 67.97 61.99 62.73 
SD 13.63 14.98 16.71 
EMOTION* 
mean 55.56 56.12 47.58 
SD 10.63 9.73 14.81 
DISEASE OUTCOME MEASURES 
DISTRESS 
mean 60.29 62.75 48.02 
SD 10.23 9.95 11.20 
DISABILITY 
mean 5.51 16.11 0.39 
SD 8.73 14.61 1.03 
DISRUPTION 
mean 12.93 17.32 1.52 
SD 13.77 15.16 3.10 
PROBLEM*= Problem-focused coping, EMOTION*= emotion-focused coping 
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Table 7: Univariate comparisons and post hoc tests for 
social, personal and disease outcome measures 
for the control (C), SLE and MS groups. 
SCALES 
SOCIAL RESOURCES 
df p LSD* 
HASSLES 1.19 2,106 .3082 C>MS>SLE 
UPLIFTS 5.43 2,106 .0057 C>MS>SLE 
NETWORK .64 2,106 .5281 SLE >C>MS 
SUPPORT 4.55 2,106 .0127 C>MS>SLE 
PERSONAL RESOURCES 
EFFICACY 3.69 2,106 .0283 C>SLE>MS 
PROBLEM* 1.62 2,106 .2043 SLE>C>MS 
EMOTION* 5.89 2,106 .0037 MS>SLE>C 
DISEASE OUTCOME MEASURES 
DISTRESS 
21.13 2,106 .0001 MS>SLE>C 
DISABILITY 24.81 2,106 .0001 MS>SLE>C 
DISRUPTION 17.69 2,106 .0001 MS>SLE>C  
*Groups with a common underline do not have significantly different means 
PROBLEM*= Problem-focused coping, EMOTION*= emotion-focused coping 
4.2.0 RELATIONSHIPS BETWEEN THE VARIABLES 
The correlation matrices for the separate groups are presented in Table 8, 
with statistically significant coefficients being indicated by bold type. 
More variables were significantly correlated for the control group and 
fewer for the SLE sufferers. The dissimilar correlation patterns are 
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considered further in the discussion as explanations for the group 
differences observed above. 
4.3.0 PREDICTING DISEASE OUTCOMES 
Stepwise multiple regression was used to determine which social and 
personal resource variables predicted disease outcomes and to establish 
the strength of their relationships. An inspection of the correlations 
between variables (Table 8) suggests they interact differentially to 
influence disease outcomes for the different groups. Consequently 
stepwise regressions were performed separately for each group. An 
F—to—enter value of 4.17 was derived from the degrees—of—freedom for 
the smallest group [SLE sufferers df=(1,32)]. 
DISTRESS 
For the SLE group, social and personal resources were not correlated 
with psychological distress scores. In the stepwise analysis, however, 
hassles and uplifts predicted psychological distress scores (Table 9). At 
step one hassle scores were entered into the equation R 2 = .18, [F (1, 32) 
= 7.12, p<.051. Uplifts were entered at step two 1R 2 = .30, [F (2,31) = 6.51, 
p<.01]. No additional variables were entered into the equation. The 
standardised regression coefficients suggest decreasing uplifts and 
increasing hassles are associated with elevated psychological distress. 
For the MS group, none of the observed social and personal variables 
were significantly correlated with the measure of psychological distress 
(Table 9). 
88 
Table 8: Correlation matrices for SLE (n=34), 
MS (n=37) and control (n=38) groups*. 
SLE A B C D E F G H I HASSLES 	 A 
UPLIFTS 	 B .07 
NETWORK 	 C -.11 .11 
SUPPORT 	 D -.51 .06 .23 
EFFICACY 	 E -.11 .23 -.12 .30 
PROBLEM* 	 F -.01 .27 -.00 .22 . 3 6 
EMOTION* 	 G .27 .00 -.25 -.14 .08 .55 
DISTRESS 	 H . 4 3 -.31 -.13 -.35 -.34 -.22 .22 
DISABILITY I .27 -.08 .11 -.26 -.13 .16 .04 .12 
DISRUPTION I . 6 9 -.07 .01 -.46 -.26 -.07 .21 .54 . 6 2 
MS A B C D E F G H I 
HASSLES 	 A 
UPLIFTS 	 B . 3 6 
NETWORK 	 C -.08 .23 
SUPPORT 	 D -.17 . 3 6 .26 
EFFICACY 	 E -.09 .21 .17 . 4 8 
PROBLEM* 	 F -.13 . 5 1 .26 . 4 4 . 6 1 
EMOTION* 	 G .12 .28 .26 .25 .10 .49 
DISTRESS 	 H .23 .22 .10 -.28 -.29 -.02 -.03 DISABILITY I -.06 -.17 -.15 -.56 -.13 -.13 -.26 .33 DISRUPTION! .19 -.19 .17 -.54 -.53 -.30 .06 .64 . 4 6 
CONTROLS A B C D E F G H I 
HASSLES 	 A 
UPLIFTS 	 B . 3 7 
NETWORK 	 C -.19 .30 
SUPPORT 	 .D -.30 .15 . 4 2 
EFFICACY 	 E -.16 .00 .10 . 4 1 
PROBLEM* 	 F .28 . 7 5 .23 .02 -.01 
EMOTION* 	 G . 5 4 . 6 1 -.07 -.34 -.36 .69 
DISTRESS 	 H .31 .10 -.48 -.54 -.41 .21 .60 DISABILITY I .05 -.14 -.24 -.08 -.08 .02 -.12 -.04 DISRUPTION J . 4 6 .10 -.10 -.21 -.15 .36 . 3 3 .43 .23 
* 	 Statisticaly significant correlations (p<.05) are in bold type 
PROBLEM*= Problem-focused coping, EMOTION*= emotion-focused coping resource measures 
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Table 9: Summary of the stepwise regression for variables predicting 
psychological distress. 
Variable SE B 
SLE Hassles .23 .08 .45 
RZ=.30 Uplifts -.15 .07 -.34 
MS No significant predictors 
CONTROLS Emotion* .43 .09 .57 
R-Z=.56 Network -.83 .21 -.44 
Emotion*=emotion-focused coping 
For control controls, emotion-focused coping, social support and 
network size were correlated with psychological distress (Table 8). In the 
stepwise analysis, emotion-focused coping was first entered into the 
equation R2 = .36, [F (1, 36) = 20.56, p<.011 (Table 9). At step two, 
network size was entered 1 2 = .56, [F (2, 35) = 21.98, p<.01]. After step 
two, the remaining variables did not have an F-value greater than 4.17 
and were not entered into the equation. The standardised regression 
coefficients indicated that a small social 'network and more 
emotion-focused coping was associated with higher psychological 
distress scores for control controls. 
PHYSICAL DISABILITY 
For the SLE group, social and personal resource measures were not 
correlated and did not predict physical disability levels. For the MS 
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group, however, social support was significantly correlated with and 
predicted physical disability levels E.2 = .32, [F (1, 35) = 16.18, p<.01]. 
From the standardised regression coeficient (Table 10) more physical 
disability was associated with less social support. For control group, 
social and personal resource measures were not correlated and did not 
predict physical disability levels. 
Table 10: Summary of the stepwise regression for variables predicting 
physical disability levels. 
Variable 	 SE B 
SLE 	 No significant predictors 
MS 	 Social support 	 -.95 	 .24 	 -.56 
R-Z=.32 
CONTROLS 	 No significant predictors 
PSYCHOSOCIAL DISRUPTION 
For the SLE group, disruption was correlated with hassles and social 
support. However, hassle levels were the only significant predictor of 
psychosocial disruption for SLE suferers a2 = .48, [F (1, 32) = 28.99, 
p<.01] (Table 11). Higher hassle levels were associated with more 
psychosocial disruption. 
Social support and self-efficacy were significantly correlated with 
disability levels for MS volunteers. These, in addition to network size, 
predicted psychosocial disruption levels (Table 11). Social support was 
entered at step one a2 = .29, [F (1, 35) = 14.06, p<.01], network size at step 
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two 1R2 = .39, [F (2, 34) = 10.81, p<.01] and self-efficacy levels at step three 
R2 = .50, [F (3, 33) = 10.84, p<.01]. Higher psychosocial disruption levels 
were associated with less social support and self—efficacy, as well as a 
larger network size. 
Table 11: Summary of the stepwise regression for variables predicting 
psychosocial disruption. 
Variable SE B 
SLE Hassles .48 .08 .68 
RZ=.48 
MS Support -.79 .25 -.45 
RZ=.50 Network .64 .23 .35 
Efficacy -.44 .16 -.37 
CONTROLS Hassles .06 .02 .46 
RZ=.21 
For healthy controls, emotion— and problem—focused coping were 
correlated with disruption scores for healthy controls. Nevertheless, 
hassle levels were the only significant predictor of psychosocial 
disruption for the control group R2 = .21, [F (1,36) = 9.82, p<.01]. Where 
a moderate increase in hassles were associated with more psychosocial 
disruption. This finding is, however, unreliable given the large 
proportion of participants scoring zero disruption. 
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Chapter Five 
Discussion 
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5.1.0 OVERVIEW 
The discussion parallels the results section, commenting first on the 
group differences for social, personal and disease outcome measures. For 
several measures, the limited research with SLE sufferers makes the 
findings difficult to interpret theoretically. By comparing Correlation 
matrices (Table 8), however, some provisional hypotheses about the 
processes underlying group differences can be generated. The second 
section discusses the significance of social and personal variables in 
predicting disease outcome measures. 
5.2.0 GROUP COMPARISONS 
SOCIAL RESOURCES 
The MANOVA for social resource measures was statistically significant. 
Group differences were present for the uplifts and social support scales, 
but not of the hassle or network measures. 
HASSLES 
Although significant group differences were not evident on the hassles 
(stress) measure, controls reported marginally higher rates than the illness 
groups. This finding is contrary to the prediction that stress levels would 
be substantially elevated in the illness groups and may be reconciled by 
examining the methodology of published research. 
Published research implies that high stress precedes disease exacerbations, 
but does not consider whether levels differ from other chronic illnesses 
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or 'healthy' controls (e.g., Laing et al., 1984; Rimon & Kronqvist, 1988). 
These studies also use hospitalised samples and may, therefore, be biased 
towards individuals with few coping skills or a more serious illness. 
Furthermore, they neglect to consider possible confounding between 
symptomatology, recent changes in the availability of social support and 
stress (see Thoits, 1985 for a review). 
There also may be behavioural explanations for the observed differences 
in reported stress levels. For example, SLE sufferers may implicitly or 
explicitly avoid stress as they are more susceptible to its deleterious effects. 
Alternatively, being chronically ill may limit the range of activities in 
which individual can participate and hence the potential for stress. 
Taking account of activity levels would thus be more appropriate for 
assessing the effects of stress. 
The interaction of hassles with the other variables provides another 
explanation of the possible processes underlying group differences. For 
the SLE group, high stress and low social support lead to psychological 
distress and psychosocial disruption. This finding is consistent with the 
buffering hypothesis of social support and is widely supported by research 
(see Cohen & Wills, 1985 for a review). High stress levels were associated 
with more positive events for MS sufferers, but not with disease outcome 
measures. This suggests high activity levels are both pleasurable and 
stressful for MS sufferers but are less important to disease outcome. For 
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controls, high stress [and uplifts] in the presence of emotion—focused 
coping leads to psychosocial disruption. 
Whereas studies suggest SLE sufferers experience elevated stress levels, 
this finding may result from methodological limitations such as a lack of 
comparisons groups, using seriously ill hospitalised sufferers and 
confounded stress assessments. The low stress levels also may result from 
behavioural factors such as leaving the work force or avoiding potentially 
stressful activities. Correlational data suggest stress in the absence of 
sufficient social support may lead to psychological distress in SLE sufferers. 
UPLIFTS 
Whereas SLE research uses daily hassle methodology, the 
contradistinction that uplifts (or positive events) are important predictors 
of disease outcome is not widely investigated. Using the latter measure, 
significant differences in the number of uplifts were evident with controls 
differing from the chronic illness groups. 
This finding is consistent with the notion that chronic illness limits 
activity and hence access to pleasurable events. Cognitive styles that 
disregard the positive aspects of events or high psychological distress 
levels also may influence reporting of pleasurable events, with distressed 
individuals reporting fewer pleasurable events (Macgillivray & Baron, 
1994). 
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The interaction of uplifts With other variables may also suggest reasons for 
group differences on the scale. Uplifts were not correlated with any social, 
personal or disease outcome measure for the SLE group. Thus, uplifts are 
less important to the well-being of SLE sufferers. For the MS group, 
uplifts are associated with more social support, problem-focused coping 
and stress. They were, however, unrelated to the disease outcome 
measures. Thus, for individuals with MS, activity levels may depend on 
the presence of social support which in turn promotes problem-focused 
coping. Uplifts were associated with more stress, problem- and 
emotion-focused coping for the control group. For controls, high activity 
levels promote both more positive and negative coping strategies. 
SOCIAL NETWORKS AND SOCIAL SUPPORT 
Although not statistically significant, SLE sufferers reported more social 
network members than either control or MS subjects. This finding is 
interesting as it suggests that there has been no decrease in network size in 
the SLE group over the course of the disease. When compared with the 
illness groups however, control subjects reported significantly more social 
support. Thus, despite embeddedness in a social network, chronic illness 
sufferers may received less social support than healthy people. The 
correlation matrices may provide insight into how and why social 
relationship vary between the groups. 
For healthy controls, social support is influenced differentially by social 
and personal resource variables. Social network size and social support 
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are highly correlated, suggesting embeddedness is associated with 
potentially more social support. High social support also is associated 
with greater self—efficacy and using less emotion—focused coping. Low 
social support and a small network are related to increased psychological 
distress, but not to the other disease outcome measures. Causal 
associations aside, the intercorrelations between variables suggest that low 
self-efficacy and emotion—focused coping in the presence of low social 
support are associated with less psychological distress in healthy people. 
For the SLE group, social support is associated with different social and 
personal resource variables. Lower social support was associated with 
more stress and psychosocial disruption. That is, there was evidence for 
the buffering model of social support. 
For MS sufferers, high social support was significantly associated with 
greater self—efficacy, problem—focused coping and more uplifts. The 
aforementioned correlations suggest that positive events are associated 
with greater self—efficacy which improves problem—focused coping and 
enhances social support levels. This hypothesis has some support from 
the notion that social support promotes coping assistance which in turn 
minimises negative disease outcomes (Thoits, 1986). 
Another important implication from these post hoc analyses is that social 
support is differentially related to disease outcome measures. For control 
subjects, low social support was associated with more psychological 
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distress, but not the other indices of health status. This finding is 
unsurprising given that controls were selected for their absence of ill 
health. For SLE sufferers, high social support was associated with less 
psychosocial disruption, but not with psychological distress or disability. 
Thus, high social support may have a buffering role against psychosocial 
disruption. Equally low levels of social support may be a consequence of 
psychosocial disruption. For the MS group, low social support was 
associated with greater physical disability and psychosocial disruption and 
unrelated to psychological distress scores. It is possible that high disability 
mitigates social support levels which in turn lead to increases in 
psychosocial disruption (Brown et al., 1989). 
Although it was theoretically possible to investigate the buffering 
hypothesis for social support in the present study, this is not 
recommended when data is cross-sectional (Felner et al., 1983; Thoits, 
1985; Cohen & Wills, 1985; Gottieb, 1988). Cross-sectionally, high stress 
levels have been a demonstrated consequence of low social support and 
low stress levels are correlated with high social support (Felner et al., 1983; 
Thoits, 1985; Cohen & Wills, 1985; Gottieb, 1988). Thus, preexisting stress 
levels may be an outcome of existing social support. Furthermore, high 
stress levels may arise from a loss of social support, again confounding 
outcomes. The aforementioned difficulties make longitudinal data that 
controls for time-1 levels of stress and social support the minimal 
requirement for testing the buffering hypothesis (Felner et al., 1983; 
Thoits, 1985; Colien et al., 1985; Cohen & Wills, 1985; Gottieb, 1988; Brown 
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et al., 1989; Fitzpatrick et al., 1991). 
PERSONAL RESOURCES 
The MANOVA for personal resource measures was statistically significant. 
Group differences were present for the self—efficacy and emotion—focused 
coping scale, but not of the problem—focused coping measure. 
SELF—EFFICACY 
The prediction that self—efficacy levels would be significantly higher for 
controls than for either illness group was supported. The antecedents of 
lowered levels are not evident from this study, but it is likely that the 
unpredictable relapsing and remitting course of SLE may lower 
self—efficacy perceptions as individuals believe they lack the skills to 
alleviate symptomatology. 
The group differences may again be clarified by considering the association 
of efficacy with other variables. For both chronic illness groups, 
problem—focused coping was significant related to self—efficacy. This 
finding also has been reported with RA sufferers (Schiaffino et al., 1991). 
For SLE sufferers, self—efficacy was not significantly related to any other 
social, personal or outcome variables. For individuals with MS, high 
self—efficacy was related to low disability which is consistent with findings 
from other studies (O'Leary et al., 1988; Schiaffino et al., 1991). High 
self—efficacy also was significantly related to higher social support which is 
again consistent with the findings from other studies (O'Leary et al., 1988). 
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Thus, for SLE sufferers high self-efficacy may promote problem-focused 
coping or vice versa, and for MS sufferers this relationship is further 
mediated by high social support and disability levels. 
For controls high self-efficacy was correlated with high social support. It 
also was correlated with using fewer emotion-focused coping strategies, 
but not with problem-focused coping. Thus, self-efficacy may promote 
social support and limit unproductive emotion-focused coping. 
PROBLEM- AND EMOTION-FOCUSED COPING 
No significant group differences were present on the problem-focused 
coping measure. Significant group differences on the emotion-focused 
coping measure were evident. The chronic illness group used more 
emotion-focused strategies than control subjects. Thus, chronically ill 
individuals use problem-focused strategies as often as healthy controls. 
They also use more emotion-focused strategies that are less advantageous 
to overall well-being. This finding is not widely reported, as most 
researchers classify individuals as either emotion- or problem-focused 
copers to compare outcome measures (e.g., Brown et al., 1989; Revenson & 
Felton, 1989; Newman et al., 1990). This typology is not justified in the 
present study as emotion- and problem-focused coping were highly 
correlated in all the groups (Table 8). 
Group differences in coping strategies also may be clarified by considering 
their association with other variables. For the chronic illness groups, 
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individuals using problem—focused coping strategies reported higher 
self—efficacy scores. No evidence was found for the previously reported 
finding that emotion—focused coping would be significantly associated 
with either low self—efficacy [or high disability] scores (Revenson & 
Felton, 1989). No other significant associations between coping and the 
other variables were evident for SLE sufferers. For the MS group, high 
scores on the problem—focused coping scale were associated with more 
positive events and social support. Furthermore, individuals with high 
scores on the emotion—focused coping scale reported less psychosocial 
disruption. Finally, in the chronic illness groups no support was found 
for problem—focused coping being associated with lower disability levels 
(Newman et al., 1990), emotion—focused coping being associated with 
more psychological distress (Brown et al., 1989) or problem—focused 
coping being associated with less psychological distress (Brown et al., 
1989). 
For controls, coping was complexly related to the other variables. Higher 
problem—focused coping scores were associated with more uplifts and 
psychosocial disruption. Higher emotion—focused coping scores were 
associated with more hassles, uplifts, psychological distress and 
psychosocial disruption. Emotion—focused coping also was associated 
with less social support and lower self—efficacy scores. Thus, it appears 
that when coping is important, both emotion— and problem—focused 
coping strategies are employed. Individuals with higher emotion—focused 
scores, however, experience lower social support and lower self—efficacy 
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levels. It is implicit from the correlation matrix for controls that 
emotion—focused coping may be adaptive at low levels, but detrimental to 
personal or social resources when used extensively. The COPE scale may 
also have multicollinearity problems, with emotion—focused items 
overlapping with measures of social support, psychological distress and 
psychosocial disruption. 
DISEASE OUTCOME MEASURES 
The MANOVA for disease outcome measures was statistically significant. 
Group differences were present for the psychological distress, disability 
and psychosocial disruption measures. 
PSYCHOLOGICAL DISTRESS 
The prediction that chronic illness would be associated with more 
psychological distress was supported, with distress levels being comparable 
between SLE and MS sufferers, who both differed significantly from 
controls. 
For the SLE group, psychological distress was associated with more hassles 
and psychosocial disruption. These findings have been widely reported 
(e.g. Otto & Mackay, 1967; Laing et al., 1984; Rimon & Kronqvist, 1988; 
Wekking et al., 1991) in SLE sufferers. Curiously, other social and personal 
resources variables were not associated with psychological distress scores 
suggesting specific etiological factors in SLE sufferers. For the MS group, 
higher psychological distress was related to more psychosocial disruption. 
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No other significant correlations were evident for MS sufferers. For 
controls, high psychological distress was associated with a smaller social 
network and less social support. These findings have been widely 
reported in studies with healthy people (see Cohen & Wills, 1985 for a 
review). Psychological distress also was associated with using more 
emotion—focused coping and greater psychosocial disruption. 
DISABILITY AND PSYCHOSOCIAL DISRUPTION 
The groups were significantly different on the disability measure with MS 
sufferers scoring higher than SLE, who in turn differed from controls. 
This finding is unremarkable as controls subjects were selected for the 
absence of illness. The higher score of MS sufferers was also expected, as 
this group experiences more mobility problems than SLE sufferers. 
Psychosocial disruption scores for the chronic illness groups also differed 
significantly from controls. With scores of SLE and MS sufferers being 
comparable due to symptomatology causing disruption independently of 
its etiology. The lower scores for control subjects are unremarkable as this 
group were free from ill health. 
The Disease Exacerbation Model predicted a deterioration in all social and 
personal resources as well as in disease outcomes. While significant 
decrements were observed on all disease outcome measures when 
comparing the chronic illness and control groups, there were some social 
and personal resources not apparently influenced by the course of disease. 
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In particular, there was no significant difference between the chronic 
illness and control groups on measures of hassles, network size or 
problem—focused coping. These findings provide a significant 
qualification in refining the scope of the Disease Exacerbation Model for 
chronic illness. 
5.3.0 PREDICTORS OF DISEASE OUTCOME 
While group differences may be partially explained by the differential 
interaction of variables, their importance in disease outcome was 
established through stepwise multiple regression analyses. The discussion 
again parallels the results section format. 
PSYCHOLOGICAL DISTRESS 
For the SLE group, hassles in the absence of uplifts predicted psychological 
distress and accounted for 30 percent of the variance. Uplifts appear to 
have a buffering or compensatory effect in that they were not significantly 
associated with psychological distress in the correlation matrix (Table 8). It 
is consistent with studies using 'healthy people' and the theoretical 
underpinnings of hassle and uplift research proposed by Delongis and 
associates (1988). That is, high stress in the absence of counterbalancing 
uplifts (positive events) leads to psychological states such as anxiety and 
depression as well as physical symptomatology (Delongis et al., 1988). 
There were no predictors for psychological distress in the stepwise model 
for MS sufferers. This finding is consistent with correlational data. That 
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is, psychological distress was not significantly correlated with either social 
or personal resource variables. Thus psychological distress in MS sufferers 
is influenced by variables not included in the current model and has a 
different etiology than for the SLE group. 
For the control group, emotion—focused coping and a small social network 
predicted psychological distress. These variables accounted for 56 percent 
of the observed variance for psychological distress scores. This etiology is 
different to the hassles and uplifts model observed in SLE sufferers, and 
implies a main—effect for social networks in the presence of poor coping 
(Cohen & Wills, 1985). 
PHYSICAL DISABILITY 
For the SLE and control groups, neither social nor personal resources 
predicted disability scores. Since controls were selected for an absence of 
illness and hence disability, the null relationship is not unexpected. The 
lack of a significant relationship for SLE sufferers suggests that disability 
levels are not mediated by social and personal resources for SLE sufferers. 
For individuals with MS, however, insufficient social support predicted 
higher disability scores and accounted for 32 percent of the variance. This 
suggests that social support is important in assisting individuals to 
overcome mobility and related problems (Wineman, 1990). 
PSYCHOSOCIAL DISRUPTION 
-For controls and SLE sufferers, high hassles were associated with more 
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psychosocial disruption. For the SLE group, 48 percent of psychosocial 
disruption was attribute to hassles and is consistent with research findings 
(e.g. Otto & Mackay, 1967; Laing et al., 1984). For the MS group, 50 percent 
of psychosocial disruption was attributable to low social support in the 
presence of a large social network and poor self-efficacy. 
5.4.0 SUMMARY AND CONCLUSIONS 
This study examined the social, personal and disease outcome differences 
between SLE, MS and healthy control subjects. This comparative design 
provided partial support for the Disease Exacerbation Model of chronic 
illness. It demonstrated that individuals with SLE experienced similar 
problems to MS sufferers (with the exception that MS sufferers reported 
significantly more disability) and that both illness groups differed from 
healthy controls. 
Both chronic illness groups reported less social support, more 
emotion-focused coping and lower self-efficacy. In addition, the chronic 
illness groups reported more psychological distress, disability and 
psychosocial disruption. No significant differences were, however, found 
between the chronic illness groups and healthy controls on the hassles, 
network size, or problem-focused coping measures. Some social and 
personal resources of ill people, therefore, remained intact despite 
suffering from a chronic disease. 
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The correlation matrices demonstrated that social, personal and disease 
outcome measures interact differentially to influence group differences. 
These interactions are, however, best investigated longitudinally 
controlling for time-1 levels of the variables. For example, the buffering 
hypothesis could not be adequately investigated with cross-sectional data 
as high stress has been demonstrated to be a function of low social support 
levels (Thoits, 1985; Cohen & Wills, 1985). 
For the SLE group, hassles appear to be the most important moderator of 
disease outcome, but may be buffered by uplifts. Social support also was 
significantly related to psychosocial disruption and may be a mitigating 
factor. For MS sufferers, social support, networks and self—efficacy are the 
important social and personal resource variables mediating disease 
outcomes. While useful for comparison purposes, the regression 
findings are less unreliable for controls, as these individuals were free 
from chronic illness. 
There are several methodological problems in this present study that limit 
the generalisation of findings. Individual matching was not possible in 
the present study because of limitations of available participants in the 
chronic illness groups. Furthermore, other social and personal resources 
not included in the present study may also be important mediators of 
disease outcomes. These include social resources such as negative social 
support transactions, as well as the personal resources such as cognitive 
styles and control. Finally, some of the hypotheses of interest in studying 
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the course of chronic illness are not adequately tested in a cross—sectional 
designs. For example, the buffering hypothesis for social support requires 
longitudinal data for adequate assessment. Despite these limitations, the 
present study has contributed to the identification of social and personal 
resources impacted upon by the process of two chronic diseases. It also has 
identified which social and personal resources potentially act as mediators 
in the disease process and has implications for intervention studies that 
may influence the course of chronic illness. 
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Social and Personal Resources as Mediators of Disease Outcome in 
Chronic Ilness and Healthy People 
CONSENT FORM 
You are probably aware that having systemic lupus erythematosus 
(SLE)/multiple sclerosis (MS) may effect the quality of your life. 
Disruptions to life style could arise from disability, pain, restricted social 
contacts, your fatigue or medication. These stresses may make it more 
dificult to cope, lead to anxiety or depression and prolong exacerbations. 
Research is currently underway investigating how SLE /MS efects the 
quality of your life. The study is open to people with SLE/MS throughout 
Tasmania, irrespective of the severity of your condition or where you live. 
The study is currently underway and involves two short interviews and 
some questionnaires to complete in your own time. A research assistant 
wil visit you at home and help you to complete the questionnaires. If this is 
inconvenient other arrangements can be made. Al information you 
provide wil be kept confidential and only group data wil be reported in 
scientific publications. You may withdraw from the study at any time, if you 
wish to do so. 
If you would like more information you can contact Helen Hornsby Ph. (002) 
202889 during ofice hours or the SLE/MS Society. 
I have read and understand the consent form 
Name 	  
Address 	  
Signature 	 Date 	  
Witness 	  
121 
REVISED DIAGNOSTIC CRITERIA FOR 
SYSTEMIC LUPUS ERYTHEMATOSUS 
:ed below is the diagnostic criteria for systemic lupus erythematosus. Please Eorse the symptomatology your patient sufers, by ticking the appropriate box [ 1. our patient is not a systemic lupus erythematosus sufferer, but fits some of the 
)w criteria, endorse the appropriate symptomatology. Over the page is a place for 
[ to specify your patient's diagnosis. 
Criterion 	 Definition 
[ ] 	 Malar Rash 	 Fixed erythema, flat or raised, over the malar eminences, tending to spare the nasolabial folds. 
[ ] 	 Discoid Lupus 	 Erythematosus raised patches with adherent keratotic scaling and folicular plugging; 
atrophic scaring may occur in older lesions. 
Photosensitivity 	 Skin rash as a result of unusual reaction to 
• sunlight, by patient history or physician 
observation. 
[ ] 	 Oral ulcers 	 Oral or nasopharyngeal ulceration, usualy painless, observed by physician. 
[ ] 	 Arthritis 	 Nonerosive arthritis involving two or more peripheral joints, characterised by tenderness, sweling, or efusion. 
Serositis a.Pleuritis- convincing history of pleuritic pain or rub heard by a physician or evidence of pleural 
efusion 
OR 
b.Pericarditis- documented by ECG or rub or evidence or pericardial efusion. 
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Renal 	 a. Persistent proteinuria greater than 0.5g/day or 
Disorder 
	
	 greater than 3+ if quantitation not performed 
OR 
b. Celular casts- may be red cel, hemoglobin, 
granular, tubular, or mixed. 
Neurologic 	 a. Seizures- in the absence of ofending drugs or 
Disorder 	 known metabolic derangements; e.g., uremia, 
ketoacidosis, or electrolyte imbalance 
OR 
b. Psychosis- in the absence of ofending drugs or 
known metabolic derangements; eg., uremia, 
ketoacidosis, or electrolyte imbalance. 
Hematologic 	 a. Hemolytic anemia- with reticulocytosis 
Disorder 	 OR 
b.Leukopenia- less than 4000/mm3 total on two or 
more occasions 
OR 
c.Lymphopenia- less than 1500/mm3 on two or 
more occasions 
OR 
d.Thrombocytopenia- less than 100,000/mm3 in 
the absence of ofending drugs. 
Immunologic 	 a. Positive LE cel preparation 
Disorder 	 OR 
b.Anti-DNA: antibody to native DNA in 
abnormal titer 
OR 
c.Anti-Sm: presence of antibody to S m nuclear 
antigen 
OR 
d.False-positive serologic test for syphilis known 
to be positive for at least 6 months and 
confirmed by Treponema palidum 
immobilization or fluorescent treponemal 
antibody absorption test. 
Antinuclear 	 An abnormal titer of antinuclear antibody by 
Antibody 	 immunofluorescence or an equivalent assay at 
any point in time and in the absence of drugs 
known to be associated with "drug-induced 
lupus" syndrome. 
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DEMOGRAPHIC INFORMATION 
Gender: 	 Female 	 [ ] 	 Male 	 [ ] 	 Age 	  
Marital Status: single 	 [ I 
married 	 [ I 
separated 	 [ I 
divorced 	 [ ] 
widowed 	 [ I 
Do you live (tick as many as apply): 
on your own 	 [ I 
with your spouse partner 	 [ ] 
with friends 	 [ I 
with brothers and/or sisters [ ] 
with parents 	 [ i 
with your children 	 [ I 
other, specify 	  
Occupation 	  
If a dependent, breadwinner's occupation 	  
If a pensioner or unemployed, previous occupation 
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How old were you when diagnosed? 	  
How long before diagnosis did you sufer from lupus/MS? 	  
List any medication(s) prescribed to relieve your symptoms over the past 6 
months. Include the dosage level, frequency of ingestion, and how long you have 
been taking each medication. 
a. medication 	 b. medication 	  
dosage 	 dosage 	  
frequency 	 frequency 	  
duration_ 	 duration 	  
c. medication._ 	 d. medication 	  
dosage 	 dosage 	  
frequency 	 frequency 	  
duration_ 	 duration 	  
To what extent do the folowing medication side efects interfere with your daily 
functioning (e.g. ability to do housework, work or socialise). 
a. increased appetite or weight gain 
no disruption 	 severe disruption 
b. depression 
no disruption 	 severe disruption 
c. stomach irritations 
no disruption 	 severe disruption 
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d. fluid retention or moon face 
no disruption 	 severe disruption 
e. dizziness 
no disruption 	 severe disruption 
f. slow healing injuries 
no disruption 	 severe disruption 
g. being easily bruised 
no disruption 	 severe disruption 
Lupus/MS is characterised by periods of flare and remission. A flare occurs when your 
symptoms increase in intensity, possibly causing you considerable discomfort and 
distress. Remission occurs when there is an interval or break in the intensity of your 
symptoms, your discomfort is usualy reduced. 
What is your current ilness condition? 
flare 
remission 
early stage of a flare 
late stage of a flare 
never experienced a flare 
"under control" (i.e., medication 
is preventing a flare) 
not sure 
[ 
[ 
[ 1 
[ 1 
[ 1 
[ 
[ 1 
About how long have you experienced your current (as above) ilness condition? 
126 
INSTRUCTIONS 
HASSLES are irritants things that annoy or bother you; they can make you upset or 
angry. UPLIFTS are events that make you feel good; they can make you joyful, glad, 
or satisfied. Some hassles and uplifts occur on a fairly regular basis and others are 
relatively rare. Some have only a slight effect, others have a strong effect. 
This questionnaire lists things that can be hassles and uplifts in day-to-day life. 
You will find that during the course of a day some of these things will have been 
hassles for you and some will have been only an uplift. Others will have been both 
a hassle AND an uplift. 
DIRECTIONS: Please think about how much of a hassle and how much of 
an uplift each item was for you today. Please indicate on the left-hand side 
of the page (under "HASSLES") how much of a hassle the item was by 
circling the appropriate number. Then indicate on the right-hand side of 
the page (under "UPLIFTS") how much of an uplift it was for you by circling 
the appropriate number. 
Remember, circle one number of the left-hand side of the page and one number 
on the right-hand side of the page for each item. 
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HASSLES AND UPLIFT SCALE 
How much of a hassle was 	 How much of an uplift 	was 
this item for you today? 	 this item for you today? 
HASSLES 	 UPLIFTS 
0 = None or not applicable 	 None or not applicable =0 
1 = Somewhat 	 Somewhat = 1 
2= Quite a bit 	 Quite a bit = 2 
3 = A great deal 	 A great deal = 3 
0 1 2 3 1. Your child(ren) 0 1 2 3 
0 1 2 3 2. Your parents or parents-in-law 0 1 2 3 
0 1 2 3 3. Other relative(s) 0 1 2 3 
0 1 2 3 4. Your spouse 0 1 2 3 
0 1 2 3 5. Time spent with your family 0 1 2 3 
0 1 2 3 6. Health or wel-being of a family 
member 
0 1 2 3 
0 1 2 3 7. Sex 0 1 2  3 
0 1 2 3 8. Intimacy 0 1 2 3 
0 1 2 3 9. Family related obligations 0 1 2 3 
0 1 2 3 10. Your friend(s) 0 1 2 3 
2 3 11. Felow workers 0 1 2 3 
0 1 2 3 12. Clients, customers, patients, etc. 0 1 2 3 
0 1 2 3 13. Your supervisor or employer 0 1 2 3 
0 1 2 3 14. The nature of your work 0 1 2 3 
0 1 2 3 15. Your work load 0 1 2 3 
0 1 2 3 16. Your job security 0 1 2 3 
0 1 2 3 17. Meeting deadlines or goals on the job 0 1 2 3 
128 
HASSLES 	 UPLIFTS 
HASSLES 	 UPLIFTS 
0 = None or not applicable 	 None or not applicable =0 
1= Somewhat 	 Somewhat =1 
2 = Quite a bit 	 Quite a bit = 2 
3 = A great deal 	 A great deal =3 
0 1 2 3 18. Enough money for necessities (e.g., 
food, clothing, housing, health care, 
taxes, insurance) 
0 	 12 	 3 
0 1 2 3 19. Enough money for education 
0 1 2 3 20. Enough money for emergencies 
0 1 2 3 21. Enough money for extras (e.g., 
entertainment, recreation, vacations) 
1 2 3 22. Financial care for someone who 
doesn't live with you 
0 1 2 3 23. Investments 
0 1 2 3 24. Your smoking 
0 1 2 3 25. Your drinking 
0 1 2 3 26. Mood-altering drugs 
0 1 2 3 27. Your physical appearance 
0 1 2 3 28. Contraception 
0 1 2 3 29. Exercise(s) 
0 1 2 3 30. Your medical care 
0 1 2 3 31. Your health 
0 1 2  3 32. Your physical abilities 
0 1 2  3 33. The weather 
0 1 2  3 34. News events 
0 1 2 3 35. Your environment (e.g., quality of 
air, noise level, greenery) 
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HASSLES 	 UPLIFTS 
0= None or not applicable 	 None or not applicable =0 
1 = Somewhat 	 Somewhat =1 
2 = Quite a bit 	 Quite a bit = 2 
3 = A great deal 	 A great deal =3 
0 1 2 3 36. Political or social issues 0 1 2 3 
0 1 2 3 37. Your neighbourhood (e.g., 
neighbours, setting) 
0 1 2 3 
0 1 2 3 38. Conserving (gas, electricity, water 
petrol etc.) 
0 1 2 3 
0 1 2 3 39. Pets 0 1 2 3 
0 1 2 3 40. Cooking 0 1 2 3 
0 1 2 3 41. House work 0 1 2 3 
0 1 2 3 42. Home repairs 0 1 2 3 
0 1 2 3 43. Yardwork 0 1 2 3 
0 1 2 3 44. Car maintenance 0 1 2 3 
0 1 2 3 45. Taking care of paperwork (e.g., 
paying bils, filing of forms) 
0 1 2 3 
0 1 2 3 46. Home entertainment (e.g., TV, 
music, reading) 
0 1 2 3 
0 1 2 3 47. Amount of free time 0 1 2 3 
0 1 2 3 48. Recreation and entertainment 
outside home (e.g., movies, sports, 
eating out, walking) 
0 1 2 3 
0 1 2 3 49. Eating (at home) 0 1 2 3 
0 1 2 3 50. Church or community organisations 0 1 2 3 
0 1 2 3 51. Legal matters 0 1 2 3 
0 1 2 3 52. Being organised 0 1 2 3 
0 1 2 3 53. Social commitments 0 1 2 3 
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NSSQ 
List each significant person in your life. Consider al the persons who have 
been important to you in the past 6 months. When listing individuals use 
only their first name or initials. Additionaly, specify your relationship (e.g., 
spouse, family or relatives, friend, work associate, neighbour, general 
practitioner, counselor etc.) with each of the nominated persons. 
Name 	  
Date 	  
First name or initials 
	
1. 	  
2. 	  
3. 	  
4. 	  
5. 	  
6. 	  
7. 	  
8. 	  
9. 	  
10. 	  
11. 	  
12. 	  
13. 	  
14. 	  
15. 	  
16. 	  
17. 	  
18. 	  
19. 	  
20. 	  
Relationship 
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ISEL 
This scale is made up of a list of statements each of which may or may not be true 
about you. For each statement we would like you to circle TRUE if the statement 
is probably true about you or FALSE if the statement is probably not true about 
you. 
You may find that many of the statements are neither clearly true or clearly false. 
In these cases, try to decide quickly whether TRUE or FALSE is most descriptive 
of you. Although some questions wil be dificult to answer, it is important that 
you pick one alternative or the other. 	Remember to circle only one of the 
alternatives for each statement. 
1. There is at least one person I know whose advice True / False 
I realy trust. 
2. Most of my friends are more interesting than I am. True / False 
3. I feel that I'm on the fringe in my circle of friends. True / False 
4. I am more satisfied with my life than most people 
are with theirs. 
True / False 
5. I am able to do things as wel as most other people. True / False 
6. When I feel lonely, there are several people I could 
cal and talk to. 
True / False 
7. There are very few people I trust to help solve my problems. True / False 
8. I have someone who takes pride in my accomplishments. True / False 
9. There is someone I can turn to for advice about handling 
hassles over household responsibilities. 
True / False 
10. Most people I know think highly of me. True / False 
11. If I got stranded ten kilometers out of town, there is 
someone I could cal to come and get me. 
True / False 
12. I think that my friends feel that I'm not very good at 
helping them solve problems. 
True / False 
13. If I needed some help in moving to a new home, I 
would have a hard time finding someone to help me. 
•True / False 
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14. If I decide on a Friday afternoon that I would like to 
go to a movie that evening, I could find someone to go 
with me. 
True / False 
15. I feel that there is no one with whom I can share my most 
private worries and fears. 
True / False 
16. In general, people don't have much confidence in me. True / False 
17. If a family crisis arose few of my friends would be able to 
give me good advice about handling it. 
True / False 
18. When I need suggestions for how to deal with a personal 
problem I know there is someone I can turn to. 
True / False 
19. There is no one I could call on if I needed to borrow a car 
for a few hours. 
True / False 
20. There is really no one I can trust to give me good 
financial advice. 
True / False 
21. I regularly meet or talk with members of my family 
or friends. 
True / False 
22. If I need a quick emergency loan of $100, there is 
someone I could get it from. 
True / False 
23. There is someone who I feel comfortable going to 
for advice about sexual problems. 
True / False 
24. In general people do not have much confidence in me. True / False 
25. If I were sick, there would be almost no one I could find 
to help me with my daily chores. 
True / False 
26. If I needed a ride to the airport very early in the morning, 
I would have a hard time finding anyone to take me. 
True / False 
27. No one I know would throw a birthday party for me. True / False 
28. If for some reason I were put in jail, there is someone True / False 
I could call to would bail me out. 
29. Most of my friends are more successful at making 
changes in their lives than I am. 
True / False 
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30. Most people I know don't enjoy the same things 
that I do. 
True / False 
31. If I were sick and needed someone to drive me to the 
doctor, I would have trouble finding someone. 
True / False 
32. There are several different people with whom I enjoy 
spending time. 
True / False 
33. If I had to mail an important letter at the post office by True / False 
5:00 pm and couldn't make it, there is someone who 
could do it for me. 
34. I don't often get invited to do things with others. True / False 
35. There is someone I could turn to for advice about 
changing my job or finding a new one. 
True / False 
36. If I wanted to have lunch with someone, I could easily 
find someone. 
True / False 
37. I have a hard time keeping pace with my friends. True / False 
38. If I had to go out of town for a few weeks, someone I know 
would look after my home (the plants, pets, yard, etc.). 
True / False 
39. There is really no one who can give me objective feedback 
about how I'm handling my problems. 
True / False 
40. I am closer to my friends than most other people. True / False 
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Read each statement carefuly. 	 Circle the number that best describes how you feel. 
There are no right or wrong answers. 
Not at al 
like me 
A little 
like me 
Somewhat 
like me 
Very much 
like me 
1.Once I know what I need to do, 1 2 3 4 
I can do it. 
2.In a new situation I expect I 
can handle things. 
1 2 3 4 
3.I am a confident person. 1 2 3 4 
4.I am not very efective in 
solving problems. 1 2 3 4 
5.When I'm stressed, I can count 
on myself to cope successfuly. 1 2 3 4 
6.I am not a self-assured person. 1 2 3 4 
7.I have control over my reactions 
to stress. 
1 2 3 4 
8.I can usualy get what I want. 1 2 3 4 
9.I rely on my inner strength to 
deal with problems. 
1 2 3 4 
10.The good things that happen to 1 2 3 4 
• me are largely my own doing. 
11.I'm proud of myself. 1 2 3 4 
12.I do not have a high opinion 
of my abilities. 
1 2 3 4 
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Not at all 
like me 
A little 
like me 
Somewhat 
like me 
Very much 
like me 
13. I wish I had more confidence in 1 2 3 4 
my ability to succeed in life. 
14. People know they can expect a 1 2 3 4 
lot from me. 
15. I believe I use my skills to their 1 2 3 4 
best advantage. 
16. I am responsible for the ways I 1 2 4 
have grown as a person. 
17. I can influence the people in my 1 2 3 4 
life. 
18. I make my interactions with 1 2 3 4 
people end up the way I expect 
them to. 
19. I am quick to learn new things 1 2 3 4 
about ways to deal with 
problems. 
20. I am not afraid to make 
mistakes. 1 2 3 4 
21. I know what people expect from 1 2 3 4 
me. 
22. I question my abilities in difficult 1 2 3 4 
situations. 
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1 = I usually don't do this at all 
2 = I usually do this a little bit 
3 = I usually do this a medium amount 
4 = I usually do this a lot 
1. I try to grow as a person as a result of the expereince 1 2 3 4 
2. I turn to work or other substitue activities to take my 
mind off things. 1 2 3 4 
3. I get upset and let my emotions out. 1 2 3 4 
4. I try to get advice from someone ablout what to do. 1 2 3 4 
5. I concentrate my efforts on doing something about it. 1 2 3 4 
6. I say to myself "this isn't real." 1 2 3 4 
7. I put my trust in God. 1 2 3 4 
8. I laugh about the situation 1 2 3 4 
9. I admit to myself that I can't deal with it, and quit qucikly. 1 2 3 
10. I restrain myself from doing anything too quickly. 1 2 3 4 
11. I discuss my feelings with someone. 1 2 3 4 
12. I use alcohol or drugs to make myself feel better. 1 2 3 4 
13. I get used to the idea that it happened. 1 2 3 4 
14. I talk to someone to find out more about the situation. 1 2 3 4 
15. I keep myself from getting distracted by other thoughts 
or activities. 1 2 3 4 
16. I daydream about things other than this. 1 2 3 4 
17. I get upset, and am really aware of it. 1 2 3 4 
18. I seek God's help. 1 2 3 4 
19. I make a plan of action. 1 2 3 4 
20. I make jokes about it. 1 2 3 4 
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21. I accept that this has happened and that it can't be changed. 1 2 3 4 
22. I hold off doing anything about it until the situation 
permits. 1 2 3 4 
23. I try to get emotional support from frinds or relatives. 1 2 3 4 
24. I just give up trying to reach my goal. 1 2 3 4 
25. I take additional action to try to get rid of the problem. 1 2 3 4 
26. I try to lose myself for a while by drinking alcohol or 
taking drugs. 1 2 3 4 
27. I refuse to believe it has happened. 1 2 3 4 
28. I let my feelings out. 1 2 
29. I try to see it in a different light, to make it seem more 
positive. 1 2 3 4 
30. I talk to someone who could do something concrete 
about the problem. 1 2 3 4 
31. I sleep more than usual. 1 3 4 
32. I try to come up with a strategy aboutwaht to do. 1 2 3 4 
33. I focus on dealing with this problem, and if necessary 
let other things slide a little. 1 2 3 4 
34. I get sympathy and understanding from someone. 1 2 3 4 
35. I drink alcohol or take drugs, in order to think about it less. 1 2 3 4 
36. I kid around about it. 1 2 3 4 
37. I give up the attempt to get what I want. 1 2 3 4 
38. I look for something good in waht is happening. 1 2 3 4 
39. I think about how I might best handle the problem. 1 2 3 4 
40. I pretend that it hasn't really happened. 1 2 3 4 
41. I make sure not to make matters worse by acting too soon. 1 2 3 4 
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42. I try hard to prevent other things from interfering with 
my efforts at dealing with this. 1 2 3 4 
43. I go to movies or watch TV, to think about it less. 1 2 3 4 
44. I accept the reality of the fact that it happened. 1 2 3 4 
45. I ask people who have had similar experiences what 
they did. 1 2 3 4 
46. I feel a lot of emotional dsitress and I find myself 
expressing those feelings alot. 1 2 3 4 
47. I take direct action to get around the problem. 1 2 3 4 
48. I try to find comfort in my religion. 1 2 3 4 
49. I force myself to wait for the right time to do something. 1 2 3 4 
50. I make fuin of the situation. 1 2 3 4 
51. I reduce the amount of effort I'm putting into solving 
the problem. 1 2 3 4 
52. I talk to someone about how I feel. 1 2 3 4 
53. I use alcohol or drugs to help me get hrough it. 1 2 3 4 
54. I learn to live with it. 1 2 3 4 
55. I put aside other activities in order to concentrate on this. 1 2 3 4 
56. I think hard about what steps to take. 1 2 3 4 
57. I act as though it hasn't even happened. 1 2 3 4 
58. I do what has to be done, one step at a time. 1 2 3 4 
59. I learn something from the experience. 1 2 3 4 
60. I pray more than usual. 1 2 3 4 
